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Heterogenous nuclear ribonucleoproteins (hnRNPs) are predominantly nuclear and have been 
shown to be involved in multiple cellular processes. There are more than 20 members of hnRNP 
protein family and they all bind RNA. Some hnRNPs like the ones in hnRNP H family was 
shown to have sequence specific RNA binding activity. hnRNP H potein family includes hnRNP 
H1, H2. H3 and F. This study mapped the location of hnRNP H/F binding site on the SV40 Late 
(SVL) pre-mRNA relative to the polyA signal. The binding site is characterized down to five 
consecutive Guanines. Disruption of hnRNP H/F binding site on the SVL pre-mRNA had a 
negative effect on polyadenylation in vitro and this effect is translated to downregulated gene 
expression in Gfp based in vivo assays. The fact that this effect was seen with constructs having 
single polyA sites implicates a pronounced effect on alternative polyadenylation. The second 
part of this study involves microarray experiments with A20 B-cell lymphoma and AxJ 
Plasmacytoma cells. More than 400 genes were found to be differentially expressed in AxJ cells. 
While this group includes many known B-cell stage specific genes, there are also numerous 
novel differentially expressed transcripts. The list includes transcription, splicing and 
polyadenylation factors, too. Elongation factor RNA polymerase II 2 (ELL2) is induced in AxJ 
cells as assayed by microarray and RT-PCR experiments. The overexpression of hnRNP F was 
shown revert the B-cell clock, in so as far as secretory to membrane Immunoglobulin ratio is 
concerned. In an attempt to identify the genes underlying this mechanism, microarray 
experiments were preformed with hnRNP F overexpressing AxJ plasmacytoma cells and 
 iii
compared the gene expression profile with the one of mock transfected cells. There are about 30 
differentially expressed transcripts upon forced expression of hnRNP F. Three B-cell stage 
specific genes were differentially expressed in hnRNP F overexpressing AxJ cells. ELL2 is 
among these genes. ELL2 is a known transcriptional elongation enhancer. A novel model 
regarding the secretory to membrane Immunoglobulin switch and involving ELL2 is proposed. 
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 1. STATEMENT OF PROBLEM 
While the polyadenylation reaction requires multiple basal factors, it has been hypothesized that 
there are tissue specific modifiers of polyadenylation. Our lab (Veraldi et al. 2001) isolated 
polyadenylation (pA) complexes from cell lines representing early B-cells and plasma cells.  The 
two proteins hnRNP F and H were found in a larger complex when the pA complex was 
reconstituted from early/memory B-cell extract. The location of the binding region of these two 
proteins relative to the pA signal was unmapped;  the determination of their binding region on 
RNA might help explain the mechanism of action of these two proteins. The positive effect of 
hnRNP H on SV40 late pre-mRNA polyadenylation in vitro has been reported (Bagga et al. 
1998). On the other hand, the hnRNP F was shown to have a negative effect on 3’ cleavage 
reaction in vitro (Veraldi et al. 2001). The question of whether hnRNP H and F have opposite 
effects on polyadenylation or if they act together in the same direction remains to be answered. 
Even though they may act together in the same direction, their overall effect on polyadenylation 
may be gene specific. Furthermore, despite the extensive similarity of these two proteins, the 
possibility of differential RNA binding exists. Independent of whether they are able to bind 
different sequences or not, the optimal hnRNP H and F RNA binding sites  have yet to be 
characterized. 
While hnRNP H and F have been studied well in vitro, evidence is lacking that they do indeed 
regulate gene expression in the cell. The genomic scale analysis of the effect of these two 
proteins on gene expression will reveal whether they have a global role or act on a subset of 
specific genes 
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 2. INTRODUCTION: to the role of the hnRNP F/ H proteins in B-cell development 
This general introduction is intended to give the background about hnRNP proteins specifically 
the biological activities of hnRNP F and H proteins. The hnRNP F and H proteins were shown to 
play a specific role in B-cell development which will be elaborated in the next sections. 
Heterogenous nuclear ribonucleoproteins (hnRNPs) display sequence specific RNA binding 
activity and associate predominantly with RNA pol II transcripts (Krecic and Swanson 1999). 
Most of them are located exclusively in the nucleus while others shuttle between cytoplasm and 
nucleus. RNA binding a  ctivities of these proteins are conferred by either RNA Recognition 
Motifs (RRMs) or RGG domains or both. The name RGG comes from the common Arginine-
Glycine-Glycine repeat these domains have. RRM containing hnRNPs have multiple RRMs, 
usually at least one RRM is responsible for sequence specific binding whereas the other 
nonspecific RRMs increase the affinity of the protein to the specific sequence. RRM is an about 
80 amino acid (aa) domain that has conserved submotifs octamer RNP-1 and hexamer RNP-2. 
Each RRM can fold into a globular domain independently and this domain itself is capable of 
binding to RNA. On the other hand, there are cases in which domains other than RRMs like 
RGG and Glycine rich domains are required for optimal binding. Multiple RRM hnRNPs require 
a synergy among different RRMs for optimal or high affinity sequence specific binding. A 
typical RRM has a β1-α1-β2-β3-α2-β4 structure with RNP-1 and RNP-2 being in the central 
anti-parallel β3 and β1 strands, respectively. β3 and β1 strands were shown to interact RNA 
directly by NMR (Gorlach et al. 1992) .  
Some hnRNPs like hnRNP K and hnRNP F were shown to bind single- as well as double 
stranded DNA (Lacroix et al. 2000) (Yoshida et al. 1999). Among the many proposed functions 
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 for hnRNP proteins are mRNA trafficking, splicing, telomere length control, mRNA stability, 
transcription, polyadenylation. 
Although the RGG domain is present in hnRNP proteins frequently, the primary sequence of this 
domain varies among different proteins. For example, in nucleolin RGGF is the minimal repeat 
quartet whereas hnRNP A has only GG repeats. In addition, the RGG domain is distinct from 
Glycine hinge domains that have multiple consecutive Glycine repeats and flexible structures 
(Birney et al. 1993). 
The hnRNP H protein family consists of hnRNP H1, H2 (H’), H3 (2H9) and hnRNP F (Table 1).  
The corresponding genes are hnrp H1, H2, H3 and hnrp F, respectively. Both hnRNP H1 and H2 
(aka DSEF) are 449 aa proteins having three RRMs. The domain structures of the hnRNP H 
protein family are illustrated in Figure 1. The 96% identity between these proteins may be due to 
a recent gene duplication event.  On the other hand, hnRNP F is a 415 aa protein also having 
three RRMs. Even though it shows a 72 and 70% identity to hnRNP H1 and H2, respectively, the 
corresponding RRMs are more than 90% identical, strongly indicating that hnRNP F and hnRNP 
H1/H2 exhibit the same sequence selectivity. But hnRNP F lacks certain portions of the carboxy 
terminal domain present both in hnRNP H and H’. The 346 amino acid long hnRNP H3 is a 
relatively small variant member of the family that has been shown to have various alternatively 
spliced forms whose functions are not well characterized (Honore 2000). While all the members 
of hnRNP H family are Glycine rich (Table 1), a single amino acid Glycine makes up 24.3% of 
hnRNP H3. 
Both hnRNP F and H have been shown to bind polyG with an affinity so high that the 
interactions can persist at 2M NaCl. While there is not a general consensus for the optimal 
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 hnRNP F/H binding site, it is clear from numerous studies that multiple runs of Guanines are 
necessary and sufficient for hnRNP F/H binding. 
 
 
 
Table 1  Analysis of human hnRNP H protein family 
Analysis hnRNP F hnRNP H1 hnRNP H2 hnRNP H3 
Length 415 aa 449 aa 449 aa 346 aa 
Molecular Weight 45.7 kD 49.2 kD 49.3 kD 36.9 kD 
1 microgram = 21.9 pMol 20.3 pMol 20.3 pMol 27.1 pMol 
Isoelectric Point 5.4 5.9 5.9 6.4 
Charge at pH 7 -14.1 -7.2 -7.2 -2.3 
Chromosomal location 10q11 5 X 10q22 
# RRMs 3 3 3 2 
# Glycine (%) 51 (12.3%) 66 (14.7%) 65 (14.5%) 84 (24.3%) 
 
 
 
RRM
RRMRRMRRM
RRMRRMRRM
RRMRRMRRMhnRNP F 
 
 
 
hnRNP H1 
 
 
hnRNP H2 
 
 
hnRNP H3 
 
Figure 1 Domain structure of hnRNP 
(RRM).
  RRM 
H family proteins. Boxes stand for RNA Recognition Motif 
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 A SELEX assay has been performed neither with hnRNP F nor with H yet but possible 
quarternary Guanine structures may complicate the outcome. While the quadruplex Guanine 
structure may be important, even decisive, for binding of the hnRNP H protein family, it still 
does not change the primary recognition sequence. This structure may be pronounced in short 
oligonucleotides compared to long RNA molecules. In order to determine the consensus 
sequence in naturally occurring hnRNP H/F binding RNA molecules, all the experimentally 
hnRNP F/H bound RNAs were collected and a multiple alignment was performed (Figure 2). 
While the consensus sequence includes consecutive Guanines, an Adenine residue downstream 
of the Guanine-rich stretch is also highly conserved.  
V1loopcons       1  -AATAGTAGTAGCGTGGGGAAA--ATGATGATGGAGAAAGGAGAAATAAA 47  
Cftr-exon9-155G  1  TATTAATTTCAAGATAGAAAGAGGACAGTTGTTGGGGGTTGCTGGATCCA 50  
RSV              1  -----------------GAAUCG-ACAAAGGGGAGGAAGUGGGAGAAA-- 30  
GRSwt            1  -------------------------------GGGGGAGGUGUGGG----- 14  
Throidhorm       1  -GGCGGCCAGAGGGUGUGCGGAG-CUGGUGGGGAGGAGCUUGGAGAGAAG 48  
C-SRC            1  -------------------------CUGAGGCUGGGGGCUGCUCUCUGCA 25  
Tat              1  ------------------------UUAUCCAUUUCAGAAUUGGGUGU--- 23  
BETA-TRP         1  ------------AGUAAAUGUGGGGACCUAGAGGAGGAGCUGAAAAUUGU 38  
WA19tat          1  ---------GCCAGUUAUGAUAGGGACUUAGGGUGGGAAGCAUCCAGGA- 40  
844ins68_CBS     1  ----------ATCACTGGGGTGGATCATCCAGGTGGGGCTTTT------- 33  
Consensus        1  ----------            G-      G G GGG        A     7   
 
48 AAACTGC----------------------------------- 54  
51 CTGGAGCAGGCAAG---------------------------- 64  
30 ------------------------------------------ 30  
14 ------------------------------------------ 14  
49 GGACAAAGCUGGGGGCUGAGGGAGAACCCCCA---------- 80  
26 UGUGCUUCCU-------------------------------- 35  
23 ------------------------------------------ 23  
39 UACCAACAACUUGAAAUCUCUGGAAGCCCAAGCGGACAAGGU 80  
40 ------------------------------------------ 40  
33 ------------------------------------------ 33  
7         ----------------------------------- 7   
Figure 2 Multiple alignment of experimentally proven hnRNP F/H binding RNAs by using Clustal W 
software  
ClustalW is available at http://www.ebi.ac.uk/clustalw/ (December 2004). Consensus sequence is given at the 
bottom. Sequences were taken from (Caputi and Zahler 2002), (Pagani et al. 2003), (Fogel and McNally 2000), this 
study, (Hastings et al. 2001), (Chou et al. 1999), (Jacquenet et al. 2001), (Chen et al. 1999),  (Caputi and Zahler 
2001),  (Romano et al. 2002), respectively. 
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Figure 3 Multiple alignment of hnRNP H protein family by using BCM software.   
RRM2
RRM3
RRM1 
H1     1 MMLGAEGGEGFVVKVRGLPWSCSADEVQRFFSDCKIQNGAQGIRFIYTREGRPSGEAFVELESEDEVKLALKKDRETMGHRYVEVFKSNN 
H2     1 MMLSTEGREGFVVKVRGLPWSCSADEVMRFFSDCKIQNGTSGIRFIYTREGRPSGEAFVELESEEEVKLALKKDRETMGHRYVEVFKSNS 
F      1 MMLGPEGGEGFVVKLRGLPWSCSVEDVQNFLSDCTIHDGAAGVHFIYTREGRQSGEAFVELGSEDDVKMALKKDRESMGHRYIEVFKSHR 
H3       ------------------------------------------------------------------------------------------ 
 
 
H1    91 VEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGITLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRY 
H2    91 VEMDWVLKHTGPNSPDTANDGFVRLRGLPFGCSKEEIVQFFSGLEIVPNGMTLPVDFQGRSTGEAFVQFASQEIAEKALKKHKERIGHRY 
F     91 TEMDWVLKHSGPNSADSANDGFVRLRGLPFGCTKEEIVQFFSGLEIVPNGITLPVDPEGKITGEAFVQFASQELAEKALGKHKERIGHRY 
H3     1 --MDWVMKHNGPND---ASDGTVRLRGLPFGCSKEEIVQFFQGLEIVPNGITLTMDYQGRSTGEAFVQFASKEIAENALGKHKERIGHRY 
 
 
H1   181 IEIFKSSRAEVRTHYDPPRKLMAMQRPGPYDRPGAGRG-YNSIGRGAGFERMRRG--AYGGGYGGYDDYNGYNDGYGFGSDRFGRDLNYC 
H2   181 IEIFKSSRAEVRTHYDPPRKLMAMQRPGPYDRPGAGRG-YNSIGRGAGFERMRRG--AYGGGYGGYDDYGGYNDGYGFGSDRFGRDLNYC 
F    181 IEVFKSSQEEVRSYSDPPLKFMSVQRPGPYDRPGTARR-YIGIVKQAGLERMRPG--AYSTGYGGYEEYSGLSDGYGFTTDLFGRDLSYC 
hH3   86 IEIFRSSRSEIKGFYDPPRRLLGQ-RPGPYDRPIGGRGGYYGAGRGSMYDRMRRGGDGYDGGYGGFDDYGGYNN-YGYGNDGFDDRMRDG 
 
 
H1   268 FSGMSDHRYGDGGSTFQSTTGHCVHMRGLPYRATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEDAVAAMSKDKANMQHRYV 
H2   268 FSGMSDHRYGDGGSSFQSTTGHCVHMRGLPYRATENDIYNFFSPLNPMRVHIEIGPDGRVTGEADVEFATHEDAVAAMAKDKANMQHRYV 
F    268 LSGMYDHRYGDSEFTVQSTTGHCVHMRGLPYKATENDIYNFFSPLNPVRVHIEIGPDGRVTGEADVEFATHEEAVAAMSKDRANMQHRYI 
H3   174 RGMGGHGYGGAGDASSGFHGGHFVHMRGLPFRATENDIANFFSPLNPIRVHIDIGADGRATGEADVEFVTHEDAVAAMSKDKNNMQHRYI 
 
 
H1   358 ELFLNSTAGASGGAYEHRYVELFLNSTAGASGGAYGSQMMGGMGLSN-QSSYGGPASQQLSGGYGGGYGGQSSMSGYDQVLQENSSDFQS 
H2   358 ELFLNSTAGTSGGAYDHSYVELFLNSTAGASGGAYGSQMMGGMGLSN-QSSYGGPASQQLSGGYGGGYGGQSSMSGYDQVLQENSSDYQS 
F    358 ELFLNSTTGASN--------------------GAYSSQVMQGMGVSAAQATYSGLESQSVSGCYGAGYSGQNSMGGYD------------ 
H3   264 ELFLNSTPGGGSGMGGSGMGGYGRDGMDNQGGYGSVGRMGMGNNYSGGYGTPDGLGGYGRGGGGSGGYYGQGGMSGGGWRGMY------- 
 
H1   447 NIA 
H2   447 NLA 
F        --- 
H3       --- 
RRMs are indicated with respect to hnNRP H1. Red and green lines stand for 19aa perfect and 16aa imperfect repeats on hnRNP H1, respectively. Blue 
hexagons indicate methylation sites whereas orange hexagon sumoylation sites 
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 2.1. POSTTRANSLATIONAL MODIFICATION 
The interaction of hnRNPs and RNA could be controlled at the level posttranslational 
modifications. Various hnRNPs were found to be phosphorylated, glycosylated, methylated and 
sumoylated. Despite the fact that the primary sequence of hnRNP F and H1 are 84% similar, 
their activities can be differentially modified posttranslationally.  
The small ubiquitin-related modifier (SUMO) is an 11kD polypeptide that is attached to lysine 
residues in various proteins (Johnson 2004). SUMO is a member of the ubiquitin and ubiquitin-
like superfamily. The SUMO consensus is a tetrapeptide of B-K-X-D/E where B stands for a 
hydrophobic amino acid, K is the lysine that is covalently linked to SUMO, X is any amino acid 
and D/E is an acidic residue. The hnRNP H1, H2 and F proteins have SUMO motif in their N-
terminal  region that is lacking in hnRNP H3 (Figure 3). The SUMO motif present in hnRNP H 
family is LKKD where the first amino terminal lysine is the residue SUMO is attached. hnRNP F 
and H1 were shown to be sumoylated experimentally (Mnaimneh et al. 2004). It is highly 
probable that the same modification also takes place with hnRNP H2. For hnRNP C and M, it 
has been proposed that Sumo modification takes place at the nuclear pore complexes (NPCs) 
(Vassileva and Matunis 2004) because the SUMO modification enzymes localize to NPCs. The 
suggested mechanism of action for SUMO modification in the case of hnRNP C and M is that 
the SUMO ligation decreases the affinity of hnRNP proteins to the mRNAs so that they can be 
transported through the nuclear pores. This mechanism maybe also valid for the hnRNP H family 
since the SUMO motif is present in the first RRMs of hnRNP H1, H2 and F (Figure 3).     
The majority of nuclear asymmetric dimethylarginine (DMA) residues are found in hnRNP 
proteins. From the sequence it is clear that hnRNP H1, H2 and H3 but not hnRNP F have 
potential asymmetic dimethylarginine residues (Figure 3). While the DMA consensus is given as 
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 F/G-G-G-G-R-G-G-G/F (Kim et al. 1997), recent in vitro and in vivo studies unambigiously 
showed a second set of substrates that are loosely defined as having  the R-X-R motif (Hyun et 
al. 2000). This motif, as an RGR triplet, is present twice in hnRNP H1, H2 and H3 but is not 
present in hnRNP F at all (Figure 3). Methylation was shown to modulate the protein-RNA and 
protein-protein interactions (McBride and Silver 2001). Dimethylation is covalent and the 
amino-alkyl bond is very stable and believed to be irreversible.  
Initial studies found out that multiple hnRNPs have an uncommon modified amino acid: NG, NG-
dimethylarginine. Arginine is the single methylated amino acid in hnRNP proteins and the major 
arginine methylated isoform is NG, NG-dimethylarginine (DMA) while NG-methylarginine is 
present in minute amounts. The hnRNPs contain about 65% DMA in the cell nucleus. When 
researchers (Honore et al. 1995) analyzed methylated hnRNPs in HeLa cells they found that 
hnRNP H but not hnRNP F was methylated as expected from the primary sequence (Figure 3). 
The PolyA binding protein II (PABII) has been shown to be asymmetrically dimethylated at 16 
different Arginines (Smith et al. 1999). Twelve of these modified Arginines are in the context of 
RXR where X is a small amino acid such Gly, Ala, Ser, Pro, Tyr. Peptide based studies also 
confirmed that the GRG sequence is the preferred substrate for methylation (Rawal et al. 1995). 
While there is not experimental evidence that hnRNP H protein family is phosphorylated, they 
all have Serine and Tyrosine residues that score very high at NetPhos 2.0 software 
(http://www.cbs.dtu.dk/services/NetPhos/) and are potentially phosphorylated. Since there are so 
many potential phosphorylated amino acids, it is not possible to assess the differential effect, if 
any, of this modification to hnRNP H protein family members. 
The main function of hnRNP proteins is to protect mRNA from degradation. As soon as the 
transcript is synthesized, the proteins cover the message body so that the pre-mRNA is not 
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 sensitive to RNases. This binding can and does modulate half-life, splicing and polyadenylation 
of the transcript. The extent and the location of the hnRNP F/H binding dramatically alters the 
alternative splicing and polyadenylation pattern. 
 
2.2. TRANSCRIPTION 
The TATA-binding protein (TBP) binds to the TATA element to start the process of pre-
initiation complex assembly at the RNAP II promoters; it remains at the promoter even after 
RNAP II starts to initiate transcript synthesis. It was found that hnRNP F associates with TBP 
(Yoshida et al. 1999) through immunoprecipitation. . Interestingly, there are two isoforms of 
hnRNP F seen in 2D gels that have different isoelectric points and apparent molecular weights. 
One of the forms has a pI of 5.0 and molecular weight of about 50kD whereas the other one has a 
pI that is close to 6.0 and is about 10kD larger. The theoretical pI and MW of hnRNP F are 5.37 
and 45.7 kD as calculated by Vector Nti, respectively (Table 1). So the second isoform is clearly 
a covalently modified form of hnRNP F and most possibly it is a SUMO modified form since the 
size of SUMO is roughly 11kD. Addition of SUMO affects the stability of hnRNP proteins 
{Vassileva, 2004 #1366}. 
Although hnRNP F is expressed ubiquitously (Honore et al. 2004), it is present at high levels in 
thymus and spleen (Yoshida et al. 1999). Immunoprecipitation experiments showed a physical 
interaction between CTD of RNAP II and hnRNP F {Yoshida, 1999 #1233}.  Studies hnRNP F 
was shown to bind to the SVL promoter specifically{Yoshida, 1999 #1043}. Recombinant 
hnRNP F RRM1 and RMM3 alone could bind to poly(rG) whereas an interaction could not be 
established with RRM2 alone. Interestingly Yoshida showed that the region between RMM2 and 
3 is necessary and sufficient for polyG binding. This region consists of 38% charged amino acids 
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 and may be an indication of nonspecific binding. The fact that hnrnp F binds to RNA and DNA 
by using nonoverlapping domains raises the possibility that it can bind to both at the very same 
time. 
A yeast three hybrid screen was performed with untagged Cap Binding Protein 80 (CBP80) and 
GAL4-CBP20. The C-terminal two-thirds of hnRNP F was one of three positive clones. This 
interaction was verified by complementary in vitro binding assays and also extended to hnRNP 
H. Unlike hnRNP H1, hnRNP F preferentially binds to CBC-RNA complexes compared to 
naked RNA. This is most possibly due to the fact that the presence of CBC increases the overall 
affinity of hnRNP F to the RNA-CBC complex. The domain of hnRNP F responsible for CBP 
binding has not been determined yet. The binding of hnRNP F to the cap structure may further 
stabilize the transcript and prevent degradation. The minute amount of hnRNP F present in 
cytoplasm may also effect protein translation. 
hnRNP F can bind to the TBP and RNAP II promoters, then load to the CTD of elongating 
RNAP II. It can either unload from CTD to the 5’ cap of synthesized transcript and stabilize 
transcript or continue to travel with RNAP II. 
 
2.3. SPLICING 
2.3.1.  SILENCER 
 
The role of hnRNP H on splicing has been extensively studied with multiple different substrates. 
Given the complexity and multiplicity of the sequence elements  affecting the single splice site 
choice, an auxiliary splicing factor may not act as a silencer or enhancer all the time. On the 
other hand, it is also clear from many studies, hnRNP H1 binds to silencers in most of the cases.  
As explained below, the mechanism of silencing differs in each case. 
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 hnRNP H was shown to bind the Exonic Splicing Silencer (ESS) at the 5’ end of the alternative 
exon 7 of rat β-tropomyosin gene (Chen et al. 1999). As the authors suggested, the silencing 
activity may be exerted by the disruption of SR protein association with exon 7 because a 
putative Exonic Splicing Enhancer (ESE) is located downstream of ESS.  
In other studies, hnRNP H was shown to bind to another ESS at the 5’ extremity of HIV-1 tat 
exon 2 and represses the upstream A3 splice site required for tat mRNA production (Jacquenet et 
al. 2001). Silencing activity and binding of hnRNP H correlated in that study. It has been 
proposed that hnRNP H competes with U2AF35 subunit for binding to the exon 5’ extremity and 
exert its silencing effect by physically blocking the U2AF35 binding site. 
The 844ins68 is a frequent polymorphism of the Cystathionine β-Synthase (CBS) gene resulting 
from a 68 bp insertion. This insertion creates two identical 3’ splice sites and dual closely spaced 
G-tracts that are just downstream to the proximal 3’ss (Romano et al. 2002). Binding of hnRNP 
H to Guanine runs inhibited the proximal 3’ splice site and results in exclusive distal site 
utilization. Therefore, hnRNP H may either inhibit the recruitment of splicing factors to the 
proximal 3’ ss or interact with other splicing factors to enhance the selection of the distal site. 
The fact that the block of G-rich sequences starts just 7 nt downstream of the proximal site 
favors the former hypothesis.  
A single C toG substitution creates five consecutive Guanines in the Cystic Fibrosis 
Transmembrane Regulator (CFTR) exon 9, this in turn generates a new exonic splicing silencer 
and causes exon skipping (Pagani et al. 2003). The exon skipping activity was dominant to the 
adjacent enhancer and correlated with the binding of hnRNP H. A recent computational study 
aimed at identifying silencer elements that cause inhibition of pseudoexon splicing came up with 
three different motifs. One of three elements identified was U/GGU/AGGGG, which has been 
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 shown to have silencing effect in transfection experiments (Sironi et al. 2004). The closest match 
to this sequence among the experimentally proven hnRNP H binding sites is the element 
GUUGGGGG, which was created with the above mentioned C-G mutation in CFTR exon 9 that 
resulted in reduced exon inclusion. 
 
2.3.2. ENHANCER 
Alternatively processed exons are often characterized by suboptimal splice sites that are poorly 
recognized in the absence of enhancer sequences and trans-acting factors. HnRNP H protein 
family were shown to bind to several naturally occurring enhancer elements. 
HnRNP H and F bind to purine rich intronic element called SEα2 in the last intron of thyroid 
hormone receptor α2 (Trα2) message. This element consists of several consecutive Guanine 
residues. Binding of hnRNP F, hnRNP H  and SF2/ASF to this enhancer results in the usage of 
upstream weak 5’ splice site specific for Trα2 message (Hastings et al. 2001).  
The inclusion of c-src N1 exon in cells of neuronal origin is accomplished by an intronic splicing 
enhancer downstream of the N1 5’ splice site. The proteins that associate with this element 
include nPTB, hnRNP F, KSRP and hnRNP H. In vitro translated hnRNP F was shown to 
interact with recombinant hnRNP H at 100 mM NaCl (Chou et al. 1999) and therefore it is 
possible that hnRNP F and hnRNP H can exist as a heterodimer. HnRNP H is required for 
efficient splicing of c-src N1 exon (Markovtsov et al. 2000). 
HnRNP H interacts also with an element just downstream of a point mutation of  exon 6D in the 
HIV-1 Env gene. This interaction is required for the interaction of U1 snRNP with the enhancer. 
Binding of SC35 to the point mutant region may convert the hnRNP H-U1snRNP complex into a 
spicing enhancer. Assembly of components of U1 snRNP on Exon 6D requires hnRNP H 
binding (Caputi and Zahler 2002). 
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 In most of this cases, hnRNP F was also shown to bind these elements albeit with a significantly 
lower affinity. 
 
2.4. POLYADENYLATION  
The hnRNP H2 protein (aka DSEF) was shown to bind a downstream element of the SV40 Late 
(SVL) polyA region (Bagga et al. 1998). This element is G-rich and located 3’ to the U-rich 
sequences to which CstF-64 binds. Several lines of evidence clearly showed that binding of 
hnRNP H2 to this element has a positive effect both on 3’ cleavage and overall polyadenylation 
reactions. The effect of GRS has been shown to be position dependent; if it is placed more than 
200 nt downstream of U-rich region, its effect would be abolished (Bagga et al. 1995). 
The hnRNP F-GRS interaction has a negative effect on 3’ cleavage reaction in vitro. Binding of 
hnRNP F but not hnRNP H2 inhibits the binding of CstF-64 both to the IgM and SVL pre-
mRNA in vitro (Veraldi et al. 2001). Overexpression of hnRNP F in plasmacytoma cells resulted 
in slightly less secretory specific immunoglobulin (Veraldi et al. 2001) although membrane 
specific transcript abundance does not change. Depending on the Ig type, there are hnRNP F 
binding sites both downstream and upstream of the polyA signal. Even the negative effect of 
hnRNP F may be position dependent.  
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 3. COMMON METHODS 
RNA ELECTROMOBILITY SHIFT ASSAY PROTOCOL 
Gel apparatus was set up with 1.5 mm spacers and comb at least an hour before starting the 
experiment. If the RNA probes are more than 50 nt, a 4% gel with 20:0.25 Acrylamide to 
bisacrylamide ratio was used. Native Gel Electrophoresis buffer contains 25mM Tris Base, 25 
mM Boric acid, 1mM EDTA. 10 ml 20:0.25 Acrylamide solution, 40 ml Native Gel 
Electrophoresis buffer, 0.25g (0.5%) Agarose were mixed and this mix was heated to boiling and 
allowed to cool to 600C. Then 375 ul 10% APS and 50 ul TEMED were added and the gel 
solution was immediately poured into the gel apparatus. The gel running buffer and polymerized 
gel were stored at least an hour at 40C. If the RNA probes are less than 50 nt, then an 8% Native 
acrylamide (20:0.25) gel without agarose was used. For consistency, 8% gels were also boiled 
and cooled to 600C and then APS and TEMED were added. This procedure diminished and 
usually eliminated RNA degradation during gel running.  
A 25 tube mastermix was prepared each time. This mix contains: 7.5 ul purified Yeast tRNA 
(10mg/ml). 15 ul 100 mM DTT, 6 ul 100 mM ATP, 30 ul 500mM Creatine Phosphate, 15 ul 25 
mM MgCl2, and 187.5 ul 10% PVA. 10 ul of this mix was added to each tube. Then 1 fmol (5 
fmol if RNA probe is <50nt) radiolabeled RNA, protein and Buffer D is added to each tube. 
Every tube has 20 ul in total; volumes were equalized with Buffer D and proteins were always 
added last. Radiolabeled RNA were dissolved in 10mM TE whereas recombinant proteins were 
dissolved in Buffer D.  
After mixing reaction components well, tube was spun briefly and incubated at 300C for 20 
minutes. Then tubes were put on ice and 2 ul of 6x DNA loading dye was added to each tube. 
Samples were loaded immediately to cold gel. The gels were run at 30 mAmp, 300V 15W for 
about 1-2 hours. Gel runs were always started with cold gel and cold buffer and were then run at 
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 room temperature. It is very important to remember that the 14 nt GRS derived RNA probes run 
faster than Bromophenol blue. Then gels were dried on a gel dryer for 90 minutes and they were 
put either on the Phosphoimager or into autoradiography cassettes. Depending on the specific 
activity of the probes, Kodak X-omat film or phosphoimager screen was exposed 1-12 hours. 
 
COMPETITION RNA EMSAs 
EMSAs with tritium labeled RNA competitors were done exactly as described above except that 
the reaction tubes contain one 32P labeled and one tritium labeled RNA probe. 32P labeled probes 
were added to tubes first and then tritium probes were added. As always, protein was added last. 
Autoradiography films or Phosphoimager screens were exposed for 1-12 hours. Tritium is used 
just to calculate concentration of competitors and tritium labeled probes are not visible on films 
or phosphoimager screen. 
 
PLASMID BASED IN VITRO TRANSCRIPTION  
SV40 Late (SVL) pre-mRNA based transcripts were transcribed by using pSP65 plasmid having 
the SVL polyA region under the control of SP6 (A kind gift of Dr. Jeff Wilusz). The sequences 
of transcripts were given in Table 2. Templates for short SVL based transcripts were synthesized 
by PCR. 
One microgram of template was used in a 20 µL transcription reaction containing:  1x 
transcription buffer {40 mM Tris-HCl, pH 7.5 (SP6) or pH 7.9 (T7), 6 mM MgCl2, 2 mM 
spermidine, 10 mM NaCl (SP6 only), 10 mM DTT (T7 only)} plus 12.5 mM DTT, 25 µM rGTP, 
500 µM rCTP, rATP, rUTP each, , 20 units of RNasin™ ribonuclease inhibitor, 5µL of α-32P- 
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 Table 2   The sequence of the SVL based transcripts used in this study. 
RNA 
Probe Sequence 
247 
GAAUACACGGAAUUCGAGCUCGCCCGGGGAUCCAGACAU
GAUAAGAUACAUUGAUGAGUUUGGACAAACCACAACUAG
AAUGCAGUGAAAAAAAUGCUUUAUUUGUGAAAUUUGUGA
UGCUAUUGCUUUAUUUGUAACCAUUAUAAGCUGCAAUAA
ACAAGUUAACAACAACAAUUGCAUUCAUUUUAUGUUUCA
GGUUCAGGGGGAGGUGUGGGAGGUUUUUUAAAGCAAGUA
AAACCUCUACAAAUGUGGUAUGGCUGAUUA 
248 
GAAUACACGGAAUUCGAGCUCGCCCAACAACAACAAUUG
CAUUCAUUUUAUGUUUCAGGUUCAGGGGGAGGUGUGGGA
GGUUUUUUAAAGCAAGUAAAACCUCUACAAAUGUGGUAU
GGCUGAUUA 
249 
GAAUACACGGAAUUCGAGCUCGCCCGGGGAUCCAGACAU
GAUAAGAUACAUUGAUGAGUUUGGACAAACCACAACUAG
AAUGCAGUGAAAAAAAUGCUUUAUUUGUGAAAUUUGUGA
UGCUAUUGCUUUAUUUGUAACCAUUAUAAGCUGCAAGAA
ACAAGUUAACAACAACAAUUGCAUUCAUUUUAUGUUUCA
GGUUCAGGGGGAGGUGUGGGAGGUUUUUUAAAGCAAGUA
AAACCUCUACAAAUGUGGUAUGGCUGAUUA 
PCR-SVL-
GEM 
(Probe D) 
CAUACGAUUUAGGUGACACUAUAGAAUACACGGAAUUCG
AGCUCGCCCGGGGAUCCAGACAUGAUAAGAUACAUUGAU
GAGUUUGGACAAACCACAACUAGAAUGCAGUGAAAAAAA
UGCUUUAUUUGUGAAAUUUGUGAUGCUAUUGCUUUAUUU
GUAACCAUUAUAAGCUGCAAUAAACAAGUUAACAACAAC
AAUUGCAUUCAUUUUAUGUUUCAGGUUCAGAAUACACGG
AAUUCGAGCUCGGU 
Probe F 
CAUACGAUUUAGGUGACACUAUAGAAUACACGGAAUUCG
AGCUCGCCCAACAACAACAAUUGCAUUCAUUUUAUGUUU
CAGGUUCAGAAUACACGGAAUUCGAGCUCGGU 
Probe E 
GAAUACACGGAAUUCGAGCUCGCCCGGGGAUCCAGACAU
GAUAAGAUACAUUGAUGAGUUUGGACAAACCACAACUAG
AAUGCAGUGAAAAAAAUGCUUUAUUUGUGAAAUUUGUGA
UGCUAUUGCUUUAUUUGUAACCAUUAUAAGCUGCAAUAA
ACAAGUUAACAACAACAAUGGGGAUCCUCUAGAGUCGAC
CUGCAGGCAUGCAAGCUU 
GRS GGGGGAGGUGUGGG 
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 GTP (3000 Ci/mmol; 10mCi/ml), and 50 units SP6 or T7 RNA polymerase.  The reaction was 
incubated at 370C for one hour.  The DNA template was then digested by addition of 0.5 µL of 
10 Units RNase-free DNase I  with an incubation at 37°C for 15 minutes.  The reaction was 
stopped by addition of 30 ul 0.1 M Tris and 50 ul 2xSDS buffer to a final volume of 100 ul. The 
radioactivity in 1 ul of the samples was determined with Scintillation counter. Then RNA 
transcripts were Phenol-Chloroform extracted and Ethanol precipitated and resuspended in 10 µL 
formamide loading dye (80% formamide, 1xTBE, 0.25% xyline cyanol, 0.25% bromophenol 
blue) and purified from a 5 % polyacrylamide-8M urea gel.  
 
IN VITRO TRANSCRIPTION WITH DNA OLIGONUCLEOTIDE TEMPLATES 
All the transcription templates were ordered from DNA synthesis Center, Department of 
Biological Sciences Pittsburgh PA. Two oligos were used for each transcription: one only has the 
T7 promoter, the other having the antisense to the T7 promoter and antisense to wildtype or 
mutant GRS. This means for every oligo transcription., T7 promoter primer was always used, so 
only the second primer differed. The sequences of wild type and all 20 mutant GRS DNA oligo 
templates are given in Table 3. Mutations are also in antisense form but whenever they are 
transcribed, we get sense mutant GRS RNA Oligo. 
A reaction mix containing 4 µg of each oligo was incubated at 950C for 3 minutes in 0.025M 
EDTA and 10mM TE; then these samples were added to an in vitro transcription mix after being 
chilled for one minute on ice. The transcription reaction was performed as described below. We 
started with four ug of template because the rate limiting step in these reactions is transcriptional 
initiation. 
A 14 nt scrambled RNA transcript SAA-SCR was created by using an identical strategy.  
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 Table 3   Oligonucleotides used for in vitro transcription reactions. 
Oligo Name SEQUENCE 
wtGRS CCCACACCTCCCCCTATAGTGAGTCGTATAT 
SAA1 CCCACACCTCCCCTTATAGTGAGTCGTATAT 
SAA2 CCCACACCTCCCTCTATAGTGAGTCGTATAT 
SAA3 CCCACACCTCCTCCTATAGTGAGTCGTATAT 
SAA4 CCCACACCTCTCCCTATAGTGAGTCGTATAT 
SAA5 CCCACACCTTCCCCTATAGTGAGTCGTATAT 
SAA6 CCCACACTTCCCCCTATAGTGAGTCGTATAT 
SAA7 CCCACATCTCCCCCTATAGTGAGTCGTATAT 
SAA8 CCCATACCTCCCCCTATAGTGAGTCGTATAT 
SAA9 CCTACACCTCCCCCTATAGTGAGTCGTATAT 
SAA10 CTCACACCTCCCCCTATAGTGAGTCGTATAT 
SAA11 TCCACACCTCCCCCTATAGTGAGTCGTATAT 
SAA12 CCCACACCTCCCTTTATAGTGAGTCGTATAT 
SAA13 CCCACACCTCCTTCTATAGTGAGTCGTATAT 
SAA14 CCCACACCTCTTCCTATAGTGAGTCGTATAT 
SAA15 CCCACACCTTTCCCTATAGTGAGTCGTATAT 
SAA16 CCCACATTTCCCCCTATAGTGAGTCGTATAT 
SAA17 CTTACACCTCCCCCTATAGTGAGTCGTATAT 
SAA18 TTCACACCTCCCCCTATAGTGAGTCGTATAT 
SAA19 CCCACACCTTCTCCTATAGTGAGTCGTATAT 
SAA20 CCCACACCTTTTCCTATAGTGAGTCGTATAT 
SAA-SCR TCACGATACTGAGTTATAGTGAGTCGTATAT 
T7prom ATATACGACTCACTATA 
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 PURIFICATION OF OLIGORIBONUCLEOTIDES 
After transcription with T7 RNAP, samples were subjected to DNase I digestion with 10 Units of 
DNase I at 370C for 15 min. The Superfine G-25 RNA grade Sephadex media was purchased 
from Amersham Pharmacia and empty columns were purchased from Pharmacia. Columns were 
set up according to Pharmacia’s instructions and they were stored in 20% Ethanol at 40C. The G-
25 Sephadex columns were initially spun for two minutes at 750g to get rid of the 20% Ethanol 
used as storage buffer. After this spin, samples were applied to columns, and they were spun 
another two minutes at 750g. Unincorporated nucleotides and truncated transcription products 
less than 10 nucleotides should be retained in Superfine G-25 Sephadex media whereas, at the 
same time, full length 14 nt transcripts will be in the flow through (Figure 4). By using this 
protocol, we were consistently able to get 2-15 pmol of pure RNA transcript.  
 
IN VITRO TRANSCRIPTION WITH 3H LABELED UTP 
This type of transcription reaction is very similar to the ones described above. This is written in a 
pretty chatty style. Since we have need a large quantity of tritium labeled competitors and the 
labeling percentage is not crucial, we increased the total volume of the reaction by 2.5 fold to 50 
ul. The amount each individual reagent was increased by 2.5 fold except that each rNTP amount 
was increased 10 fold. A total of 2.17x10-10 mol of 3H-UTP was used for each 50 ul reaction. 
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Figure 4 Short ribooligonucleotides were purified by using G-25 Superfine Sephadex columns. 
After in vitro transcription, transcription products were purified by using G-25 Sephadex columns as described in 
Methods section. A denaturing 12% (19:1) PAGE gel was run with purified wt GRS transcript (lane 2) and mono α-
32P-GTP (lane 1).  
 
CALCULATION OF INCORPORATION PERCENTAGE 
After in vitro transcription (IVT) reaction, 1/100 of the total volume is counted radioactivity was 
determined at the high energy channel 3 on a Beckmann Scintillation counter and the total 32P is 
calculated from this measurement. Either a denaturing Acrylamide-Urea gel was run with the 
IVT samples or if the transcript size was less than 20 nucleotides, purification was done by using 
G-25 Superfine Sephadex columns. In the former case, the corresponding bands were cut out and 
RNA is purified from the gel piece. The final Ethanol precipitated material was counted at high 
energy channel 3 and the total final counts were calculated from this measurement. This final 
total was divided by the initial total; the outcome is the Incorporation percentage. The 
incorporation percentage is multiplied with the total number of labeled and unlabeled GTP or 
UTP (Depending on the usage of α-32P-GTP or α-32P-UTP). The result was also divided by the 
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 number of Guanines or Adenines  in the transcript in order to get the total number of moles of 
transcript. 
 
RNA-PROTEIN UV CROSSLINKING ASSAY 
UV crosslinking reaction mixture contains 10-20 fmol of α-32P-GTP labeled, in vitro transcribed 
RNA, 40 µg/ml Phenol-Chloroform purified yeast tRNA, 1 mM ATP and 0.7 mM MgCl2 and 
recombinant proteins. Each sample was brought up to a final volume of 25 µl with Buffer D.  
Once again, recombinant proteins were added last in the UV crosslinking experiments. Reactions 
were mixed and incubated at 30°C for 10 minutes. Then samples were transferred to a 96-well 
microtiter plate on ice and irradiated with ultraviolet light for 12 minutes at 3000 µwatts/cm2 (1.8 
J/cm2) in a UVStratalinker 1800 (Stratagene).  Energy emitted by UV light causes covalent bond 
formation between RNA and proteins in close proximity. Unbound and unprotected RNA were 
digested with RNaseA (final concentration 50 µg/ml) at 37°C for 15 minutes and samples are run 
on a 8% (19:1) SDS-PAGE gels.  Then the gel was dried for one hour on a gel drier and the dried 
gel was exposed for 2-4 days and analyzed on the Storm 860 PhosphoImager (Molecular 
Dynamics) with the Imagequant software (Amersham Biosciences). Mobility of the proteins will 
shift to some extent since each protein is also crosslinked to short RNAs. 
 
PCR MUTATION STRATEGY 
The pSP65-SVL plasmid has about 250 nt SVL polyA region under the control of SP6 promoter. 
By having a 5’ PCR primer with T7 promoter overhang and a 3’ primer with mutant GRS 
overhang, we were able to get PCR products having aT7 promoter and a mutant GRS. All the 
PCR primers we used to create GRS mutants in the context of 225 nt SVL were given below. As 
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 a common 5’ primer we use the one labeled 248-5’CC. The T7 promoter is red shaded in this 
primer. Since we initially wanted to put the SAA18 and SAA20 mutations in the context of 225 
nt SVL, we just designed two 3’ primers for these mutants and another one for the wild type. 
248A-3’ has SAA20 whereas 248B-3’ has SAA18 mutations in them in the antisense form. The 
oligo 248wt-3’ is designed to amplify the wild type SVL. The wt SVL we amplified with 248-
5’CC and 248wt-3’ is identical to probe A. The sequences of these oligonucleotides are given in 
Table 4. 
There is one complication in this PCR however. The mt 3’ primers 248A-3’ and 248B-3’ are 46 
nt long and the former has three, while the latter has two mismatches to the pSP65-SVL plasmid. 
This means we may get a certain percentage of annealing of mt 3’ primers to the wild type SVL 
sequence present on the pSP65-SVL. We solved this issue by digesting pSP65-SVL with 
restriction enzyme MnII. One of the cutting sites of MnII is located just one nucleotide 5’ of the 
GRS and except at this site it does not cut SVL region. So we digested pSP65-SVL with MnII 
and used the digested plasmid as template. These PCR products will be used in in vitro 3’ 
cleavage assays. 
 
CLONING SVL MUTANTS TO pEGFP-C1 PLASMID 
Originally, the pEGFP-C1 plasmid (Clontech) was designed so that a second open reading frame 
can be cloned to the C-terminal multicloning site (MCS) in frame of gfp Orf. In this way, the 
protein of interest will be GFP tagged. Clontech has put the SV40 early polyadenylation signal 
just after the MCS. We found another use for this vector. Without cloning any Orf in to the 
MCS, we can take out the default SV40 early polyA site from the plasmid and put in our mutant 
or wt SVL polyA regions.  
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Table 4   Oligonucleotides used for PCR, RT-PCR or cloning based experiments. 
Oligo Name SEQUENCE 
ELL2-3' CTTCTGGTCCAAGCAGAG 
ELL2-5' AGGAGTTAAAGAAGGGTGC 
248-5'CC TAATACGACTCACTATAGAATACACGGAATTCGAGCT 
248A-3' AAAAAACCTCCCACACCTTTTCCTGAACCTGAAACATAAAATGAAT 
248B-3' AAAAAACCTCCCACACCTCCCTTTGAACCTGAAACATAAAATGAAT 
248wt-3' AAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAATGAAT 
248-5'CC TAATACGACTCACTATAGAATACACGGAATTCGAGCT 
247A-
3'CLONING 
TACCGACGCGTAAAAAACCTCCCACACCTTTTCCTGAACCTGAAACATAAAAT
GAAT 
247B-
3'CLONING 
TACCGACGCGTAAAAAACCTCCCACACCTCCCTTTGAACCTGAAACATAAAAT
GAAT 
247WT-
3'CLONING 
TACCGACGCGTAAAAAACCTCCCACACCTCCCCCTGAACCTGAAACATAAAAT
GAAT 
Eco1 AATTCGATCGGATATCAGTACTA  
Mlu1 GCTAGCCTATAGTCATGATGCGC 
 
 
There is a unique EcoRI site in the MCS of pEGFP-C1 (Clontech). About 300 bp downstream of 
MCS, there is unique MluI site. By performing double digestion, we can take out the plasmid’s 
polyA sequences without any damage to the backbone of the vector. The final task is to create 
PCR amplified mt SVL having EcoRI and MluI sites which will be used as insert. The 
previously used common 5’ primer 248-5’CC has an EcoRI site on it. We designed three other 3’ 
primers; we just added MluI sites to the 5’ of the previously used 3’ primers. Please note that 
there are also another five nucleotides 5’ of the MluI sites. They are just there to enhance MluI 
23 
 digestion. 247A-3'Cloning, 247B-3'cloning have SAA20 and SAA18 mutations on them in the 
antisense form, respectively. The sequences of these oligonucleotides were given in Table 4. 
Each PCR was performed with MnII digested pSP65-SVL plasmid and common 5’ primer 248-
5’CC and one of the 3’ cloning primers. The final PCR products will 252 nt (224 nt SVL plus 
overhangs) and EcoRI-MluI double digested PCR product size will be 219 nt which is 33 nt 
shorter than the PCR product. The digestion can be observed on a 4% Agarose gel. The 
engineered pEGFP plasmid having the SAA18 and SAA20 mutations were named pEGFP-
SAA18 and pEGFP-SAA20, respectively. 
To remove the default polyA site of the pEGFP-C1 vector, we made use of two oligonucleotides: 
Eco1 and Mlu1 (Table 4). 
Annealing of these two complementary oligos with 5’ EcoRI and 3’ MluI overhangs creates a 
perfect insert for the pEGFP vector. pEGFP-nopolyA was created by first digesting out the 
EcoRI-MluI fragment from the pEGFP-C1 and then cloning the annealed oligos into the EcoRI 
and MluI sites of pEGFP-C1. Oligos were mixed and denatured at 950C for 1 minute in 0.025M 
EDTA and 10mM TE. They are allowed to anneal at RT for seven minutes. Then the ligation 
reaction performed with annealed oligos. Annealed EcoI-Mlu1 oligos have also unique Pvu1, 
EcoRV and Sca1 restriction sites that were not present in pEGFP-C1 backbone. These unique 
sites were very useful to identify positive clones. 
 
CLONING STRATEGY: CLONING THROUGH SELECTIVE DIGESTION 
The rate limiting factor for most of the cloning experiments is the quantity of the insert. This 
problem usually is a result of inefficient gel purification of the digested fragments. Although the 
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 ligations can be done in Agarose gel pieces, this reaction also suffers from inefficiency and 
inconsistency.  
In this study, essentially all the cloning was done without gel purification of the digested 
fragments. This technique makes use of the fact that the DH5alpha bacterial cells are transfected 
with circular plasmids about 1000 times more efficiently than any linearized plasmid (Conley 
and Saunders 1984) unlike human 293T cells. After ligation was performed, unwanted ligated 
products were linearized with a final selective restriction enzyme digestion that cuts the 
unwanted circular plasmids but not the ones of interest (Spear 2000) . The final digestion was 
either performed for 16 hr at RT or for 4 hr at 370C to ensure a complete digestion. This 
technique dramatically reduced the false positive clones compared to conventional cloning 
methods. The Fast-Link ligase (Epicentre) was used for all the ligation reactions. The reactions, 
15 ul total volume, were set up with: 1.5 ul 10 mM ATP, 1.5 ul 10x Ligation Buffer (330 mM 
Tris-Acetate pH 7.8, 660 mM Potassium Acetate, 100 mM Magnesium Acetate, 5 mM DTT), 1 
ul Fast-Link Ligase (2U/ul), about 500 ng DNA and DEPC H2O. The ligation was performed at 
RT for 30 min. The Insert:vector ratio was 1:5 and 1:15. Ligation reactions were heat inactivated 
at 650C for 15 minutes prior to transformations. 
 
SELECTIVE DIGESTION AND TRANSFORMATION 
The enzyme PstI cuts between EcoRI and MluI sites of parental vector pEGFP-C1 whereas it 
does not cut any other pEGFP plasmids: i.e. pEGFP-SVLwt, pEGFP-SAA18, pEGFP-SAA20, or 
pEGFP-nopolyA (Figure 5). The PstI digestion was performed in a 15 ul reaction containing 1.5 
ul 10x PstI Buffer, 0.5 ul PstI (10U/ul), 10 ul DEPC H2O and 3 ul heat inactivated ligation mix 
(about 100 ng DNA). Although we were aware that PstI is in excess in this reaction, we 
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 performed it either for 4 hr at 370C or 16 hr at RT to ensure that the digestion went to 
completion. The PstI enzyme was inactivated at 650C for 20 min after the digestion. 
 Invitrogen’s Max Efficiency DH5alpha cells 50 ul were transferred from 1.5 ml tubes to 15 ml 
conical ones. One µl from the final digestion (about 6.7 ng DNA) was gently added to these cells 
without pipetting up and down. This mix was incubated for 30 min on ice. Then cells were heat 
shocked for 45 sec at 420C without swirling. After another 2 min incubation on ice, 250 ul of 
room temperature, rich SOC media was added to each tube. Cells were shaken for one hour at 
370C to allow npt2 gene expression. 200 ul of these cells were plated on Kanamycin plates 
(50ug/ul Kanamycin). In most of the cases, the cloning worked so well that, a 1:100 dilution of 
bacterial culture was necessary to isolate individual colonies. 
 This strategy can be applied for most of the cloning experiments. It is applied for our cloning 
experiments with enormous success with a very low false positive percentage.  
From 6-10 clones were picked from Kanamycin plates and 3 ml of YT plus Kanamycin media in 
15 ml tubes were inoculated with these clones. These cultures were grown for 16 hr at 370C. 
Plasmid minipreps (Qia-gen) were prepared from 1.5 ml of saturated cultures. The identity of the 
clones were determined by diagnostic digestions. An EcoRI-MluI double digestion was 
performed for each cloned plasmid; the cloned fragment is 216 bp in each case whereas the 
parent plasmid yields 283 bp fragment. Once we made sure that the plasmid had the appropriate 
size insert, it is sent for DNA sequencing. 
 Approximately 150 ml YT plus Kanamycin media was inoculated with 10 ul of the bacterial 
culture having the desired plasmid and this culture was allowed to grow at 370C for 16 hr. 
Approximately 100 ml of the saturated culture was used for maxi-prep plasmid purification with 
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 Qia-gen®’s maxi-prep kit. Maxi-prep procedure usually resulted in about 500 µg of plasmid 
DNA. 
pEGFP-NoPolyA
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Mlu I (1383)
Ssp I (1405)
Ssp I (1958)
polyA signal (100.0%)
polyA signal (100.0%)
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Figure 5 Plasmid maps that were used in this study. 
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 DNA SEQUENCING 
All the DNA sequencing reactions were performed by University of Pittsburgh Proteomics and 
Genomics Laboratory. The sequencing files were analyzed by Chromas 2.0 software available at 
http://www.technelysium.com.au/chromas.html (December 2004). Chromotograms 
corresponding to four of the cloned plasmids were shown in Figure 6. 
 
PHOSPHORYLATION 
Phosphorylation reactions were performed with HeLa, A20 and AxJ extracts as explained in 
(Hirose et al. 1999) 
 
ANTIBODIES 
Polyclonal rabbit anti-peptide antibodies R-7263 and R-7264 were used to detect hnRNP F and 
hnRNP H1/H2, respectively.  Horseradishperoxidase-conjugated secondary antibodies (sheep 
anti-mouse IgG and goat anti-rabbit IgG) were purchased either from Sigma or Boehringer 
Mannheim. Murine anti-RNAP II antibody is a kind gift of Dr. Baskaran Rajasekaran. Murine 
anti-GFP and anti-neomycin antibodies were purchased from Clontech and Upstate Cell 
Signaling solutions. 
 
INSTRUMENTS 
 
All UV absorbances for quantification of nucleic acid concentrations and visible absorbances for 
protein quantification were performed on a Bio-Rad Smartspec 3000 model spectrophotometer.   
Scintillation counting was performed in a Beckman Instruments model LS5000 TD counter. 
Almost all the PCR reactions were performed with Bio-Rad Icycler gradient Thermal cycler. 
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Figure 6 DNA sequencing chromotogram showing the PCR generated SAA18,  SAA20 and SAA10 
mutations located in pEGFP based plasmids.  The wild type SVL sequence is given at the top. 
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BIOINFORMATICS 
Various DNA, RNA and protein analysis were performed by Vector Nti 7.0 software. All the 
cloning experiments, plasmid map creation, PCR Oligonucleotide design, Blast searches, 
Agarose-Acrylamide gel run simulations, analysis of restriction enzyme cuts were done by using 
the same Vector Nti software. Most of the protein, DNA and RNA aligments were visualized by 
BioEdit software avalable at http://www.mgb.pitt.edu/moleculartoolbox.htm. 
 
MAMMALIAN CELL CULTURE 
A20 B-lymphoma, HeLa, 293T cells were grown as explained in American Type Culture 
Collection website (www.atcc.org). AxJ cells were grown as explained in (Veraldi et al. 2001).  
 
TRANSIENT TRANSFECTION 
Human embryonic kidney 293T cells were transfected with linearized plasmids by using 
lipotransfection method. Plasmids were linearized with Ssp1 resulting in blunt ended fragments. 
The digestion was performed for 4hr at 370C. This digestion disrupts only the f1 origin in all 
vectors. 1.5-3.0x 105 293T cells were plated on 6 well plates. 2 ug equimolar plasmid, serum free 
DMEM and Fugene 6 transfection agent (Invitrogen) were combined in 100 ul volume. This mix 
was incubated 15 min at RT and added to the wells having 2 ml serum positive DMEM. After 
incubating 18-41 hours, media (DMEM, 10% FCS, 20mM Hepes) were taken out and cells were 
washed with 1xPBS and trypsinized with 0.5 ml 1xTrypsin. After adding 2ml of serum positive 
DMEM to block trypsin, cell were spun down in 5 ml Falcon tubes. Cell pellets were 
30 
 sequentially washed with 1xPBS and then with 1xFACS buffer (5% FCS, 1xPBS, 0.01% 
NaAzide). Final cell pellets were fixed in 1xParaformaldahyde.  
 
FLOW CYTOMETRY ANALYSIS 
All the flow cytometry experiments shown in this study were performed with Coulter Epics XL 
flow cytometer operating with a single 488nm laser present in UPCI Hillman Cancer Centre, 
Pittsburgh. Both EGFP and DsRed proteins were excited with 488nm laser and emissions were 
recorded in FL1 (green) and FL3 (red) channel. EGFP is optimized for flow cytometry to be used 
with the 488 nm laser that is present in almost all flow cytometers. Since we used the optimal 
excitation wavelength of EGFP, there is a certain overlap to FL3 as in all EGFP flow 
experiments. Therefore, a modest compensation was done by subtracting 3-10% of the FL1 
channel from FL3 depending on the cell line.  A total of 5-20x103 events were recorded for each 
sample. The in depth analysis was done with the software WinMdi available at 
http://facs.scripps.edu/software.html (December 2004).  
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 4. MANUSCRIPT ONE: REGULATION OF GENE EXPRESSION BY HNRNP H’ 
AND F THROUGH FIVE CONSECUTIVE GUANINES IN 3’UTR 
4.1. ABSTRACT 
The two proteins hnRNP F and H are remarkably similar in sequence yet differ in expression 
pattern in a variety of tissues. Here, using purified proteins, the dissociation constant of hnRNP 
H to the SVL pre-mRNA was shown to be at least three fold less than that of hnRNP F when 
measured with the filter binding assay. An extensive mutational analysis in the 14 nt G-rich 
sequence (GRS) downstream of the SVL polyA site was performed and the binding of both 
hnRNP F and H was significantly diminished by the disruption of the five Guanines and 
enhanced by the presence of a downstream Adenine at position 13. Interruption of this binding 
site by mutation had a mild negative effect on in vitro polyadenylation assays and a pronounced 
effect on protein expression using the Green fluorescent protein (GFP) based reporter in 
mammalian cells. The same effect was verified by A13 mutation, with enhanced binding, 
resulting in increased GFP expression. Downregulation of hnRNP F/H levels by RNAi 
diminished the GFP level. In addition, forced expression of hnRNP F and H resulted in elevated 
gene expression. These effects were sequence specific to the G5 block. This study shows that 
both hnRNP F and hnRNP H are able to bind to the same sequence in the 3’ UTRs but with 
different affinities and that the relative levels of hnRNP F and H as well as the target RNA 
sequence can influence gene expression. 
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 4.2. INTRODUCTION 
Heterogenous nuclear ribonucleoproteins (hnRNPs) display sequence specific RNA binding 
activity and associate predominantly with RNA pol II transcripts (Krecic and Swanson 1999). 
Most of them are located exclusively in the nucleus while others shuttle between cytoplasm and 
nucleus. RNA binding activities of these proteins are conferred by either RNA Recognition 
Motifs (RRMs) or Arginine, Glycine, Glycine –rich (RGG) domains or both.  The RRM 
containing hnRNPs typically have multiple RRMs; usually at least one RRM is responsible for 
sequence specific binding whereas the other RRMs increase the affinity of the protein to the 
specific sequence.  Among the many proposed functions for hnRNP proteins are mRNA 
trafficking, splicing, telomere length control, mRNA stability, transcription, and polyadenylation 
(Krecic and Swanson 1999) . 
The hnRNP H protein family consists of hnRNP H1, H2 (DSEF or aka H’), H3 (2H9) and 
hnRNP F. The corresponding genes are hnrp H1, H2, H3 and hnrp F, respectively. hnRNP H1 
and H2 are 449 aa proteins having three RRMs (Figure 1). The 96% identity between H1 and H2 
may ensure identical physiological function; because of the identity we will use the “H” 
nomenclature for both throughout.  In contrast, hnRNP F is a 415 aa protein having three RRMs 
and it lacks the very carboxy terminal part present in hnRNP H. While it shows a 72 and 70% 
identity to hnRNP H1 and H2, overall, the corresponding RRMs are more than 90% identical.  
The 346 amino acid long hnRNP H3 is a member of the family that has been shown to have 
various alternatively spliced forms whose functions are not well characterized (Honore 2000).  
The role of hnRNP H/F on splicing has been extensively studied with multiple different 
substrates. It appears that in most of the cases hnRNP H/F bind to splicing silencers (Grabowski 
2004)  (Sironi et al. 2004). 
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 The hnRNP F protein was implicated in the polyA site choice within the immunoglobulin heavy 
chain (Veraldi et al. 2001) since over-expression of it in a plasma cell resulted in decrease in the 
usage of secretory polyA site that is normally be chosen over the membrane one. Purified hnRNP 
F inhibited binding of CstF-64 to both the secretory and membrane specific polyA sites.  The 
precise binding site of hnRNP F was not mapped.  Using an in vitro purification method of 
polyadenylation complexes (Veraldi et al. 2001) a larger complex devoid of polyadenylation 
factors was observed in A20 B-cell lymphoma containing both hnRNP F and hnRNP H proteins; 
this complex was absent in AxJ Plasmacytoma cells where hnRNP F expression is slightly lower.  
The 14 nt Guanine Rich Sequence (GRS) region in SV40 late (SVL) pre-mRNA was shown to 
bind hnRNP H2 protein, also known as DSEF-1 (Bagga et al. 1995). Binding of recombinant 
hnRNP H to GRS was shown to activate 3’ processing in vitro. Diverse pre-mRNAs including 
IVA2 and Igmu can be influenced by hnRNP H  (Arhin et al. 2002) so the question of sequence 
specificity remains. While several GRS mutants were made and analyzed in vitro (Bagga et al. 
1995), a conclusive mutation analysis of GRS region on SVL pre-mRNA had not been 
performed to determine the minimal, optimal binding site.  In one study the sequence GGGA 
was implicated as the binding site of hnRNP H family proteins (Caputi and Zahler 2001) and a 
run of Guanines in another study (Buratti et al. 2004).  When 9 out of 14 nucleotides of the SVL 
GRS were deleted the observed in vitro 3’ processing efficiency dropped about 2.5 fold (Cooke 
et al. 1999). In addition, the amount of specific polyadenylation complexes formed on the same 
mutant dropped significantly (Cooke and Alwine 2002) supporting the idea that binding of 
hnRNP H or F to the GRS increases the rate of complex formation, hence overall 3’ processing 
efficiency. 
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 To better understand the function and the effect of these two hnRNP proteins F and H on 
polyadenylation and hence gene expression, we wanted to characterize their binding region 
relative to the polyA signal and relative affinities. In this study, we have shown that hnRNP F 
and H bind a five Guanine stretch downstream of polyA site on SVL pre-mRNA.  The consensus 
binding site of hnRNP F and H includes a downstream Adenine and upstream Guanine.  
Diminishing the binding of hnRNP F and H by mutating the RNA inhibited polyadenylation in 
vitro and gene expression in vivo.  Increasing and decreasing the levels of hnRNP F and H by 
forced protein expression or RNAi in mammalian cells elevated or decreased gene expression, 
respectively, in a sequence dependent matter. Multiple lines of evidence indicate that hnRNP F 
and H proteins are important modulators of gene expression. 
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 4.3. RESULTS 
4.3.1. Mapping the binding site of hnRNP F on SVL pre-mRNA. 
 
Purified hnRNP H protein was shown to bind to a G-rich sequence (GRS) of 14 nts 
downstream of the cleavage site on SVL pre-mRNA (Bagga et al. 1995). While the three RBDs 
of hnRNP F show extensive homology to hnRNP H, the exact hnRNP F binding site on the SVL 
region had not been determined. In order to pinpoint the binding region of hnRNP F on SVL, we 
made use of 7 different SVL pre-mRNA based constructs (Figure 7). The wild type SVL RNA 
probe is 224 nt long having 3’ cleavage site and both upstream and downstream sequences. 
ElectroMobility Shift Assays (EMSAs) were performed with each of these RNA samples and 
histidine tagged recombinant hnRNP F. Since hnRNP F was shown to bind Cap binding 
complex, all the in vitro transcription reactions were performed without cap analog. Despite the 
fact that the transcripts were uncapped, RNA stability was maintained. 
We found that hnRNP F protein was able to bind three of the RNA samples: wild type 
SVL, SVL having a polyA signal mutation AAGAAA, and a portion of the SVL having only the 
downstream G-rich signal (Figure 8A and 8B). This first data set points toward hnRNP F binding 
somewhere in the region downstream of the cleavage site. 
 Substitution of the downstream cleavage region with vector pGem sequence in probe C, 
abolished the binding of hnRNP F (Figure 8B). Replacement of the 14 nt GRS with pGem 
sequences in probe D and F, also eliminated the hnRNP F binding (Figure 8A and 8B). These 
data strongly suggest that hnRNP F binds to the G-rich downstream region. Before doing any 
mutational analysis, competition gelshifts were performed to determine if the interaction 
observed between hnRNP F and GRS is a result of specific RNA-protein binding (Figure 8C and 
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 8D). The binding was able to be competed by a specific RNA (GRS+) but not by a non-specific 
RNA, demonstrating the specificity of binding. 
There are 11 Guanines in the 14 nt G-rich region downstream of GU-rich section making 
it a good candidate for the hnRNP F binding site. In order to determine if hnRNP F indeed binds 
to the GRS, we directly transcribed the 14 nucleotide GRS (Table I) by oligonucleotide based in 
vitro transcription (Milligan JF 1987). The GRS region binds to hnRNP F with reasonable 
affinity compared to wild type SVL RNA probe (Figure 8B). 
After narrowing the binding region of hnRNP F to 14 nt, we wanted to determine the 
specific nucleotides important for both hnRNP F and H binding. For this purpose, a serial single 
G→A mutation study was performed to detect which G residues are essential for the interaction 
of hnRNP F and hnRNP H. There are 11 G’s in GRS and each was mutated to A individually for 
a total of 11 single mutants. The exact sequence of each mutant is given in Table I.  
Gel shift data for single substitution mutants are summarized in Figure 4A. The most 
potent mutants are SAA3 and SAA5 which have mutation at the 3rd and 5th positions, 
respectively. These mutants show about 15-30 percent of wt GRS binding to hnRNP F and H. 
SAA10 and 11 bind to hnRNP F and H more efficiently than wt GRS. The effect of each 
mutation is similar on both hnRNP F and H binding although SAA3 and SAA9 have a slightly 
more pronounced effect on hnRNP F than on H. In summary, EMSA results indicate that the 
third and fifth G’s are the most important ones for both hnRNP F and hnRNP H binding (Figure 
9A). The SAA3 mutation disrupts the longest G-stretch in the GRS exactly in the middle. 
Then we made every possible two consecutive G→A mutations in GRS (Table 5) and 
performed EMSAs with them (Figure 9B). Mutants SAA16 and 17 are our most effective 
mutants in this case. SAA 16 has mutations at the 3rd and 4th positions whereas SAA17 is mutant 
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 at the 2nd and 3rd nucleotides (Table I). After this set of experiments, it was clear that the first 
five Guanines are decisive for both hnRNP F and H binding.  
We made two other mutants: one having mutations at the 3rd and 5th positions (SAA 19) 
the other having triple G→A substitutions between the third and fifth residues (SAA 20) (Table 
5). The latter completely knocked out both hnRNP F and H binding whereas the former showed 
some residual binding of hnRNP H as assayed by EMSA (Figure 9B).  
Mutants SAA 10 and 11 bound to both hnRNP F and H better than the original GRS by a 
factor of about two fold. While our mutation analysis showed that a Guanine stretch is critical for 
binding, it may be possible that a downstream Adenine is required for optimal binding. The non-
specific nature of quarternary Guanine structures discouraged us to pursue a possible SELEX 
experiments. However, all the experimental binding sites of hnRNP F and H present in the 
literature were collected and a multiple alignment was performed with them (Figure 2). The 
consensus binding sequence shown in Figure 2 includes a Guanine stretch, an Adenine located 8-
9 nucleotides downstream of this stretch, and an upstream Guanine. This parallels to our 
experimental results. The locations of SAA10 and 11 mutations coincide with the conserved 
Adenine when the GRS is aligned to the consensus sequence. 
The apparent dissociation constants (Kds) of hnRNP F and H to SVL pre-mRNA were 
determined precisely by using filter binding assay (Liu et al. 2002). Either the 86 nt wild type 
probe B (Figure 7) or the one having the SAA20 mutation inserted were used for the binding 
assays.  Proteins were extensively purified as described in Materials & Methods. We found that 
hnRNP H binds to wtSVL with an affinity (37 nM) that is more than three fold higher than that 
of hnRNP F (121 nM, Figure 10 and Table II). This may ensure that physiologically when both 
are  
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Figure 7 Different SVL pre-mRNA based probes that were used in this study.  
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Figure 8 hnRNP F binds to Guanine rich sequence in SVL pre-mRNA specifically. 
A) Electromobility shift assays (EMSAs) were performed with 50 pM 32P-GTP labeled SVL pre-mRNA
reactions. 0, 55, 110, 220 nM of recombinant his-hnRNP F were used to shift each RNA probe. Samples w
a 4% (20:0.25) native Acrylamide gel having 0.5% Agarose. Stars indicate the positions of hnRN
complexes. Crosshairs show the positions of unshifted RNA probes. B) EMSAs were performed as descr
Samples are run on an 8% (20:0.25) native Acrylamide gel. 250 pM probe G was used last four lanes C
were performed with 50 pM probe B and either 0.5, 5 or 50 nM specific (S) or nonspecific competitors (N
– signs stand for the presence and absence of 165 nM his-hnRNP F, respectively.  D) Quantification of lan
7-9 in C) is shown. Quantification was done by using Scion Image software ava
http://www.scioncorp.com/frames/fr_download_now.htm (December 2004). 
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  Figure 9 hnRNP F and H’ bind to five consecutive Guanines in SVL pre-mRNA.  
A) Relative binding of wt and mutant GRS oligoribonucleotides to hnRNP F and H' proteins. EMSAs were done 
with 250 pM of each probe three times with 330 nM his-hnRNP F and 210 nM GST-hnRNP H’. Binding percentage 
of each mutant relative to wtGRS is shown in the graph. Error bars represent standard error. B) Relative binding of 
mutant GRS oligoribonucleotides to hnRNP F and H' proteins. EMSAs were done as described in A). Binding 
percentage of each mutant relative to wtGRS is shown in the graph. Error bars represent standard error.  
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Figure 10  hnRNP H’ binds to SVL pre-mRNA with a higher affinity compared to hnRNP F. 
A) Binding curves of hnRNP H’ to wt probe B and probe B having SAA20 mutation as determined by filter binding 
assay. Each reaction was performed three times and error bars represent standard error. The curves are fitted to the 
experimental data points by using Prism 4 software version 4.01 (Graphpad software Inc). B) Binding curves of 
hnRNP F to very same RNA molecules were obtained as described in part A). 
 
42 
 present in equal amounts and homogenously located, the binding sites are preferentially occupied 
by hnRNP H. 
The SAA20 mutation decreased the affinity of both proteins about 4-5 fold (Figure 10 
and Table II). The only difference between the 86 nt wt and SAA20 probe is three consecutive 
G→A mutations. The filter binding data showed that hnRNP F and H have parallel sequence 
selectivity.  
4.3.2. The mutations that significantly decrease hnRNP H’/F affinities decrease 
polyadenylation efficiency 
 
To determine if decreasing hnRNP H/F binding has an effect in vitro on the strength of 
polyA site, SAA18 and SAA20 mutations (Table I) were put in the context of 224 nt SVL pre-
mRNA (Probe A in Figure 7) by PCR. Then in vitro polyadenylation assays were performed 
multiple times with these templates, a representative assay is shown in  Figure 11. Wild-type 
SVL probe was most efficient at polyadenylation. Decreasing the affinity of the hnRNP H and F 
on SVL pre-mRNA inhibited the overall polyadenylation percentage, indicating that the loss of 
the G5 tract had a negative effect on pA addition. Since hnRNP F/H depletion and add-back type 
of in vitro polyadenylation experiments have already been performed by (Bagga et al. 1998) 
(Veraldi et al. 2001), we want to extend our findings to the cell culture level. The 224 nt wt and 
mutant SAA20 and SAA10 SVL polyA regions were cloned into the 3’ Untranslated Region 
(UTR) of mammalian GFP expression plasmid pEGFP-C1 (Clontech). Human embryonic kidney 
293T cells were transfected with these constructs. Whenever GFP pre-mRNA is efficiently 
cleaved and polyadenylated, we expect to observe higher expression and more intense GFP 
fluorescence. Before testing the mutated GRS sequences in the pEGFP plasmids, we wanted to 
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 make sure that the polyA site had a measurable effect in our gene expression assay. This is 
important because  
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Figure 11  Diminishing the binding of hnRNP H’ to SVL pre-mRNA decreases the 
polyadenylation efficiency in vitro. 
Polyadenylation assays performed in vitro with internally labeled wtSVL and SVL having SAA18 and SAA20 
mutations. Lane M has a RNA marker that is 225 nt longer than unpolyadenylated SVL substrate. Last lane contains 
the reaction performed with AAGAAA polyA signal mutant. All the reaction products were run on a 5% Denaturing 
gel. 
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we made use of the pEGFP parent plasmid which has a very strong CMV immediate early 
promoter in 293T cells and the overall expression of GFP might have been so high that a single 
strong or weak polyA site might not have made a significant difference in expression. 
To construct the baseline vector, the default polyA site of the gfp open reading frame was 
removed from the pEGFP-C1 plasmid. Furthermore, the 224 nt  wtSVL polyA site was 
synthesized by PCR and the default polyA site of pEGFP-C1 was replaced by this PCR product 
(See Methods section for detail). The former plasmid was named pEGFP-nopolyA whereas the 
latter as pEGFP-wtSVL. Both plasmids were linearized before transfection and do not have any 
downstream, non-consensus polyA signals. 
We transfected 293T cells by lipid mediated transfection. After 18-41 hours of 
incubation, cells were fixed for quantitative flow cytometry analysis. Numerous replications of 
this experiment showed a very reproducible 9-10 fold induction with the wtSVL samples versus 
the no polyA construct, as quantified by flow cytometry (Figure 12 and 13A). This motivated us 
to proceed with cloning the mutants in the GFP reporter. 
Mutations SAA20 and SAA10 were inserted into the context of the 224 nt SVL construct 
by PCR, then they were cloned into the pEGFP vector. Final plasmids contain a single polyA site 
having either wtSVL or SVL with the SAA20 or SAA10 mutation. All the plasmids were 
verified by DNA sequencing; other than the mutation, they are identical. 
Quantitative flow cytometry results with the 293T cell line showed a decrease in GFP 
mean intensity of pEGFP-SAA20 and an increase with the SAA10 transfected cells (Figure 13A) 
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 relative to wild type SVL, respectively. This result correlated with our in vitro binding assays. 
Whenever there is more hnRNP H/F binding (SAA 10), more GFP is expressed and when there 
is less binding (SAA20) the opposite is true. 
The effect of the SAA20 mutation was verified by using a western blot for the GFP 
protein in the A20 and 293T transfected cells.  The A20 cell line is a B lymphoma where hnRNP 
F was relatively high (Veraldi et al. 2001).  Transfection of A20 cells showed about 2-3 fold 
repression of GFP expression in the case of pEGFP-SAA20 (Figure 13B) and 293T cells showed 
a slight decrease in GFP. Neomycin Phosphotransferase (npt2) gene is present in all pEGFP 
plasmids; the Npt2 levels serve as an internal transfection control and are comparable among 
different samples as determined by western blotting (Figure 13B). Therefore we concluded that 
weakening the H/F binding site decreases the gene expression. 
The expression difference between wtSVL and SAA20 mutant version of GFP plasmids 
is the greatest in the case of the A20 cell line (Figure 13B). We speculated that this might be due 
to an altered amount of hnRNP H and hnRNP F in A20 compared to the 293T cell line. We 
determined the relative levels of the two proteins in these cell lines by western blot (Figure 13C). 
Significantly more hnRNP H as compared to hnRNP F is found in the 293T cells whereas the 
A20 cell line has comparable hnRNP H and hnRNP F levels. In the former case, hnRNP H may 
still be present at high enough levels to show some binding to our SAA20 mutant whereas we 
believe that A20 cell line exhibits less H’ binding to the mutant. 
4.3.3. Overexpression and downregulation of hnRNP F and H has opposite  effects  on 
gene expression 
 
If our hypothesis is correct, then the modulation of the levels of hnRNP F and H would 
result in differences in gene expression on a gfp gene with a single polyA signal. We first 
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 overexpressed hnRNP F and hnRNP H separately in 293T cells (Figure 14A); the overexpression 
levels are modest, about a 20-30% increase over the endogenous protein levels. The hnRNP F 
and H overexpressing cells were cotransfected with pEGFP-SVLwt plasmid. Flow cytometric 
quantification of GFP levels shows an about 2 and 3 fold induction by hnRNP F and H forced 
expression, respectively (Figure 14B). The same experiment was repeated by replacing the 
pEGFP-SVLwt with pEGFP-SAA20. Increasing the levels of hnRNP F and H does not effect the 
gfp expression with SAA20 plasmid, since it binds the proteins very poorly and the extra 
proteins expressed by cells is not great.  This shows that the effects of hnRNP F and H are 
sequence dependent. 
The complementary experiment would be the downregulation of these two proteins by 
RNAi. However the extensive similarity between hnNRP F and H poses a problem: RNAi for 
hnRNP F could also downregulate hnRNP H, and vice versa. In addition, the hnRNP H siRNA 
should not only target hnRNP H1 but also hnRNP H2 at the same time to be effective. Having 
tried various hnRNP F and hnRNP H specific siRNA duplexes, we were finally able to get the 
two different siRNA duplexes we needed (See Methods). The hnRNP F specific siRNA only 
downregulated hnRNP F but not hnRNP H and vice versa (Figure 15A). The hnRNP H specific 
siRNA was designed to a region where H1 and H2 messages are identical but differ from hnRNP 
F (See the methods section). 
Downregulation of hnRNP H and F both resulted in slightly decreased gfp expression 
with pEGFP-SVLwt plasmid as assayed by flow cytometry (Figure 15B). Interestingly, 
whenever the pEGFP-SAA20 plasmid was transfected, the effect of downregulation by the 
siRNA was much larger (Figure 15B). A potential reason for this experimental outcome is that 
not only is the GRS mutant (=SAA20), i.e. it binds with a 4 to 5-fold reduced affinity to hnRNP 
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 F and H, but also that the hnRNP F and H levels are down by 4-5 fold. This experimental 
situation is opposite to that shown in Figure 14B where the RNA (SVLwt) binds to hnRNP F and 
H with a higher affinity and there is more hnRNP F or H in the cells.  
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Figure 14 Forced expression of hnRNP F and H resulted in induction of GFP expression  
A) Flag tagged hnRNP F and H were overexpressed in 293T cells as explained in Methods section. Western blots 
performed with anti-hnRNP F, anti-hnRNP H and anti-Flag antibodies confirmed the overexpression. Untr stands 
for untransfected cells whereas empty vector samples are the cells transfected with the backbone plasmid alone. B) 
Quantitation of GFP levels in hnRNP F and H overexpressing cells by flow cytometry. The left panel shows the data 
corresponding 293T cells cotransfected with pEGFP-SVLwt whereas the right panel with pEGFP-SAA20. 
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Figure 15 Downregulation of hnRNP F and H by siRNAs diminished the GFP expression. 
A) Western blots performed with anti-hnRNP H1/H2, anti-hnRNP F and anti-GAPDH antibodies. Untr stands for 
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 Table 5  The sequence of wt and mutant GRS oligoribonucleotides 
 GRSwt GGG GGA GGU GUG GG 
SAA1 AGG GGA GGU GUG GG 
SAA2 GAG GGA GGU GUG GG 
SAA3 GGA GGA GGU GUG GG 
SAA4 GGG AGA GGU GUG GG  
SAA5 GGG GAA GGU GUG GG  
SAA6 GGG GGA AGU GUG GG  
SAA7 GGG GGA GAU GUG GG  
SAA8 GGG GGA GGU AUG GG  
SAA9 GGG GGA GGU GUA GG  
SAA10 GGG GGA GGU GUG AG  
SAA11 GGG GGA GGU GUG GA  
SAA12 GGG GGA GGU GUG AA  
SAA13 GGG GGA GGU GUA AG  
SAA14 GGG GGA AAU GUG GG 
SAA15 GGG AAA GGU GUG GG  
SAA16 GGA AGA GGU GUG GG 
SAA17 GAA GGA GGU GUG GG 
SAA18 AAG GGA GGU GUG GG  
SAA19 GGA GAA GGU GUG GG 
SAA20 GGA AAA GGU GUG GG 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 6  Apparent dissociation constants (nM) of hnRNP F and H’ proteins to wtSVL and 
SAA20 probes. 
 
 
 
 
 
 hnRNP H’ hnRNP F 
wtSVL 37 121  
SAA20 192 545 
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 4.4. DISCUSSION 
The lack of a systematic mutation analysis had prevented a determination of the optimal 
hnRNP binding sequence for hnRNP F or H. By performing extensive mutational analysis and a 
multiple alignment with the experimentally proven hnRNP H and F sites we conclude that a run 
of five Gs and a single Adenine residue 8-9 nucleotide downstream of the Guanine core with 
another single upstream Guanine make up the consensus F/H binding site.  
We have shown that hnRNP F and H bind to the same sequences albeit with different 
affinities. The extensive similarities of RRMs of two proteins lead us to think that the observed 
differences in affinity may be due to the C-terminal-most domain present in hnRNP H but absent 
in hnRNP F. This highly charged part of hnRNP H may increase its affinity of binding without 
altering the sequence preference. 
Many RNA binding proteins have multiple RRMs that are capable of binding RNA 
independently as separate units. In contrast, most of the DNA binding proteins have a single 
DNA binding domain responsible for sequence specific binding (Biggin and Tjian 2001). For 
DNA binding proteins there is typically a single defined optimal binding sequence; any type of 
mutation in this sequence decreases the affinity significantly. On the other hand, multi RRM 
containing RNA binding proteins, especially hnRNPs, could bind to RNA with each domain 
capable of RNA recognition. There is not a single optimal RNA binding sequence in the sense 
that a minor change is well tolerated and does not decrease the apparent dissociation constant 
dramatically. In addition, unlike many DNA binding proteins, hnRNPs are very abundant in the 
nucleus and there are no competing histones binding to RNA preventing the protein-RNA 
interactions. That is perhaps why the Kds of hnRNP F and H proteins are higher compared to a 
typical transcription factor Kd, generally around single digit nM range. 
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 The observed affinity of probe G (Figure 8b) to hnRNP F is lower compared to probe A 
(Figure 8a). The reason for this observation may be that the consensus downstream Adenine and 
upstream Guanine are not present in this short oligo both of which are present in the probe A. 
The SAA20 mutant is diminished not only in the hnRNP F and H binding but also in the  
in vitro polyadenylation reaction. The effect of SAA20 mutation on in vitro polyadenylation is 
modest but reproducible. This may, in part, be due to the fact that polyadenylation in vitro  is 
very processive once it starts unlike the situation in cells where the initial synthesis of about 10 
Adenines is very slow (Wahle 1995). If an in vitro polyadenylation reaction is allowed to 
continue for extended periods, the length of the polyA tail goes well beyond the 200-300 
nucleotides.  
We have checked the potential secondary structures of the of the 86 nt wt (Probe B in 
Figure 7) and SAA20 mt SVL pre-mRNAs with the mfold software (Zuker 2003) and see no 
change of secondary structures by this criteria.  However, the observed binding affinity of 
hnRNP F to the 86 nt probe B is higher than to the 224 nt probe A (Figure 8A) suggesting that 
secondary structure in probe A might inhibit the binding of hnRNP F. Potential secondary 
structures of probe A and B were determined by using mfold software (Zuker 2003). The Gibbs 
free energy difference corresponding to probe A’s most stable secondary structure is 
significantly lower (-48.7 kcal/mole) than that of probe B (-14.1 kcal/mole) meaning that the 
former structure is noticeably more stable. This may contribute to the observed higher affinity of 
probe B than probe A to hnRNP F (Figure 8A). There is no secondary structure assigned to the 
14 nt GRS transcripts; a result we expected since G-C basepairing is not possible. Multiple 
Guanines forms quarternary Guanine structures which was not reported by Zucker algorithm. 
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 The effect of hnRNP F and H binding to the 3’ UTR of gfp reporter on gene expression in 
vivo has been verified by multiple independent lines of evidence. First, we mutated RNA, i.e. we 
made SAA10 and SAA20 mutants which bind to hnRNP F and H with a higher and lower 
affinity compared to wt SVL pre-mRNA, respectively. These mutations were placed in the 
3’UTR of gfp plasmid and transfection-based experiments showed that SAA10 and 20 have 
positive and negative effects on gfp expression, respectively. In other words, there is a 
correlation between the gfp expression and hnRNP F and H binding based on the sequence of the 
RNA. We further extended our results by keeping SVL RNA in the wild type sequence and 
overexpressing hnRNP F or H proteins. In this way, we showed increased gfp expression by 
modulating hnRNP F or H levels. Parallel to the previous SAA10 data, overexpression of either 
protein resulted in enhanced gfp expression.  Protein: RNA binding therefore controls the 
expression and changing either modulates it. On the other hand, the overexpression of hnRNP F 
or H coupled with the SAA20 plasmid cotransfection could not modulate gfp expression (Figure 
14B) since the overexpression levels are within the physiological protein levels (20-30% extra) 
instead of the 400-500% increase which would be needed to compensate for the SAA20 
mutation. The 20-30% extra hnRNP F and H was not enough to increase the binding levels to 
SAA20 plasmid, hence we observed no change in its expression with only a moderate increase in 
hnRNP F or H. 
The complementary evidence supporting our hypothesis is the RNAi mediated 
downregulation of hnRNP F and H. In the overexpression experiment, we wanted to increase the 
binding activity hence we have overexpressed the hnRNP F or H and cotransfected the cells with 
the pEGFP-SVLwt. The converse of this experiment would be the downregulation of hnRNP F 
or H coupled with pEGFP-SAA20 cotransfection. Not only do hnRNP F and H have about five 
56 
 fold lower affinity to the SAA20 mutant than the wild type but there is also 4-5 fold less hnRNP 
F and H protein in this siRNA experiment (Figure 15A). We believe that we have knocked out 
the F/H binding to RNA in this situation. This resulted in a clear reduction of gfp expression 
(Figure 15B). Since the siRNA was very effective, there is also a slight reduction of gfp levels 
when SVLwt plasmid were cotransfected (Figure 15B).  
Our in vivo experiments do not allow us to determine which is the more influential protein, 
hnRNP F or H.  When we overexpress the hnRNP proteins (Figure 14), both increase GFP 
expression by greater than 2-fold, but hnRNP F appears to increase GFP expression slightly 
more than hnRNP H does.  Nevertheless in 293T cells the hnRNP H levels are already higher 
than those of F, so hnRNP H could be close to maximal.  Meanwhile, in the siRNA knockouts 
decreasing hnRNP H levels appears to decrease GFP expression slightly more than in the hnRNP 
F knock-downs.  Since the levels of hnRNP F and H proteins were not changed to the same 
extent between the various manipulations definitive conclusions are difficult to draw.  However, 
based on ourin vitro  binding assays with pure proteins, we believe that hnRNP H should have 
the more dominant effects. Based on the previously observed formation of complexes containing 
both proteins (Veraldi et al. 2001) (Markovtsov et al. 2000) the over-expression of hnRNP F 
might be acting positively on the SVL downstream region by driving complex formation with 
hnRNP H. 
 
We have shown that hnRNP F and H proteins are modulators of gene expression through their 
sequence-specific effect on polyadenylation.  We and others have shown that hnRNP F and H 
proteins are differentially expressed in normal and cancer tissues (Veraldi et al. 2001; Honore et 
al. 2004).  The implications of our current results are that the hnRNP F/H amounts in the cell and 
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 the binding affinity of the RNA sequence of a target gene may dramatically alter the use of a 
polyA site in any multi-polyA site gene and, in genes with multiple tandem polyA sites, like the 
immunoglobulin heavy chains, the choice of polyA sites can be altered. 
4.5. MATERIALS AND METHODS 
PCR Mediated Constructs  
DNA templates that were used to create RNA probe D and F (Figure 7) were synthesized 
by PCR as explained in (Wilusz et al. 1988). The pSP65-SVL plasmid has a wild type SVL 
polyA region. Using a 5’ PCR primer with T7 promoter overhang and a 3’ primer with mutant 
GRS overhang, we were able to synthesize PCR products having T7 promoter and mutant GRS.  
All the PCR primers we used to create GRS mutants in the context of 224 nt SVL are listed 
below. The 248-5’CC primer is the common forward primer and has a T7 promoter (in italic). 
The 248wt-3’ primer was utilized as a reverse primer to create the wtSVL. On the other hand, 
248A-3’ and 248B-3’ were used to amplify the SVL having SAA20 and SAA18 mutations, 
respectively. GRS mutations are underlined and written bold.   
248-5’CC: TAATACGACTCACTATAGAATACACGGAATTCGAGCT,  
248A-3’:AAAAAACC TCCCACACCTTTTCCTGAACCTGAAACATAAAATGAAT,  
248B-3’:AAAAAACCTCCCA CACCTCCCTTTGAACCTGAAACATAAAATGAAT,  
248wt-3’:AAAAAACCTCCCACACC TCCCCCTGAACCTGAAACATAAAATGAAT. The 
PCR protocol used for each reaction consists of 30 cycles of  940C for 1 min, 580C  for 30 sec, 
720C  for 30 sec. Accupol DNA Polymerase (Genechoice) was used for each PCR reaction. 
RNAs in vitro transcribed from these templates were used for polyadenylation assays.  
Plasmid Constructs  
58 
 Plasmids that were used to create RNA probes A, B, C, E (Figure 7) for gelshifts were a 
generous gift from Dr. Jeff Wilusz and described in (Qian and Wilusz 1991). The GFP open 
reading frame on pEGFP-C1 (Clontech) has an SV40 early polyA site. By using EcoRI and MluI 
sites, this default site was removed and then the inserts produced by PCR were cloned into the 
same sites. The 5’ primer for each case is 248-5’CC whose sequence was given above. Wt and 
mt SVL having 5’ EcoRI and 3’ MluI flanking sites were synthesized by PCR as explained 
above using the following 3’ primers.  
SAA20-3'CLONING: 
TACCGACGCGTAAAAAACCTCCCACACCTTTTCCTGAACCTGAAACATAAAATGAAT,  
SAA18-3'CLONING: 
TACCGACGCGTAAAAAACCTCCCACACCTCCCTTTGAACCTGAA ACATAAAATGAAT,  
WT-3'CLONING: 
TACCGACGCGTAAAAAACCTCCCACACCT CCCCCTGAACCTGAAACATAAAATGAAT,   
SAA10-3'CLONING: 
TACCGACGCGTAAAAAACCTCTCACACCTCCCCCTGAACCTGAAACATAAAATGAAT. 
Each PCR product was double digested with EcoRI and MluI for 4 hr at 370C. All the cloning 
experiments were performed as described in (Spear 2000). 
To create pEGFP-nopolyA, the default polyA site of GFP open reading frame was 
removed from pEGFP-C1 plasmid by using EcoRI and MluI sites and two oligos were inserted 
to the same position. The sequence of both oligos are as following: 
Eco1:AATTCGATCGGATATCAGTACTA, Mlu1: CGCGTAGTACTGATATCCGATCG. 
Every cloned plasmid was verified by DNA sequencing. All the pEGFP and pDsredExpress 
vectors were linearized by SspI digestion for transfection. This only disrupts the f1 origin in all 
the plasmids. 
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 DNA Oligonucleotides, In vitro Transcription and Polyadenylation Assay 
All oligonucleotides were synthesized at the DNA Synthesis Facility, University of 
Pittsburgh. In vitro transcription reactions were performed as explained in (Milligan JF 1987) 
with the exception that no cap analog was used. The 14 nt oligoribonucleotides given in Table 1 
were produced by in vitro transcription reactions with T7 RNA Polymerase according to 
(Milligan JF 1987). Polyadenylation assays were performed with A20 nuclear extracts as 
described in (Natalizio et al. 2002).  
Protein Purification 
Plasmid pET-15b having the human hnRNP F ORF and the plasmid pGEX-2t, having human 
hnRNP H’ ORF, were kind gifts of Dr. Douglas Black and Dr. Jeff Wilusz, respectively. 
Histidine tagged hnRNP F for gelshift experiments was purified as described (Chou et al. 1999). 
To obtain highly pure and nondenatured his-hnRNP F and GST-hnRNP H’ for filter binding 
assay, a two step purification method was developed for each one. Escherichia coli (Rosetta, 
Novagen) cells were used to express both proteins. These cells have a plasmid coding for six 
tRNAs for mammalian codons that are rarely used in bacteria. Cells were grown at 370C until the 
OD600 reached 0.5. Then they were induced with 1 mM IPTG and allowed to grow at 280C for 3 
hr. The final OD600 is about 2.0. In the case of the hnRNP F purification, cells were lysed with 50 
mM Tris pH 8.0 and 1% Triton X-100 and 5 mM ATP were added to the lysed cells. Three burst 
of sonication for 20 sec at 10 Watts (RMS) were performed on ice. Cells were spun at 15,000 g 
for 15 min and the pellet was discarded. The supernatant was loaded on to a gravity operated 10 
ml DEAE-Sepharose plastic column (15 mm diameter, Pierce) that was equlibrated with 50 mM 
Tris pH 8.0. Flowthrough was collected and purified over 2 ml metal affinity Talon (Clontech) 
plastic column (7 mm diameter, Pierce) according to manufacturer’s protocol. Two step elutions 
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 were performed with 10 mM and 300 mM Imidizole; the latter has the pure his-hnRNP F (Figure 
16). In the case of hnRNP H’, the induction was done with 0.1 mM IPTG to enhance the 
solubility of the protein. The cells were lysed with 1xPBS pH 7.3 with 1% Triton-X-100 and 5 
mM ATP added. The sonication and spin were performed as described above for hnRNP F. The 
hnRNP H’ recombinant protein was first enriched by using 2 ml Glutathione-Sepharose 
(Amersham Biosciences) column according to the manufacturer’s protocol. Two-step elution 
with 1 and 100 mM Glutathione in 50 mM Tris pH 8.0 was performed and the latter contained 
the most enriched fraction. Glutathione was eliminated by buffer exchanging on a 10 ml medium 
G-25 Sephadex column. The final fractions in 1xPBS pH 7.3 were loaded to 10 ml DEAE-
Sepharose column and two step elution was performed with 250 and 750 mM NaCl; the latter 
has the pure GST-hnRNP H’ (Figure 17). Finally, both protein samples were buffer exchanged 
with Buffer D by using 10 ml medium G-25 Sephadex column and are at least 90% pure as 
assayed by Coomasiie staining. 
Electromobility Shift Assay and Filter Binding Assay 
Each gelshift reaction has 12.5 ug purified yeast tRNA, 3 mM DTT, 1.2 mM ATP, 16.7 
mM Creatine Phosphate, 0.75 mM MgCl2, 2.7% PVA, RNA and protein. 1 fmol radiolabeled 
RNA (5 fmol if RNA probe is <50nt), and the indicated amount of protein were added to each 
tube. Every tube had 20 µl in total; volumes were equalized with Buffer D (20 mM Hepes pH7.9, 
100 mM KCl, 1 mM DTT, 20% Glycerol, 0.2 mM EDTA, 1x Protease cocktail (Calbiochem) . 
All the reactions were incubated for 10-20 min at 300C. 
Acrylamide gels of 4-8% with a 20:0.25 Acrylamide:bisacrylamide ratio  were run at 30 
mAmp, 300V and 15W for about 1-2 hours. Gel running buffer contains 25 mM Tris Base, 25 
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 mM Boric acid, 1 mM EDTA. Gels were also prepared in this buffer. Gel runs were always 
started with both a cold gel and cold buffer and were performed at room temperature. 
Gelshifts with competitors were done with a 2 min pre-incubation of protein with RNA 
competitor followed by 10 min incubation of the 32P labeled probe B. The specific competitor 
was a tritium-labeled 86 nt probe B whereas the nonspecific competitor is polyA having the 
same length.  
Filter binding assays were done essentially as described (Liu et al. 2002). 
Transfection 
Cells were transfected with linearized plasmids by using Fugene 6 (Roche). 
pDsredExpress plasmid (Clontech) coding for DsredExpress protein; a variant of original Dsred 
protein(Baird et al. 2000) was used as a transfection marker. From 1.5 to 3.0x 105 cells were 
plated on 6 well plates 12-18 hours before transfection. About 2 µg equimolar plasmid, serum 
free media and Fugene 6 transfection agent with a fugene6:plasmid  ratio of 3:2 (v:w) were 
combined in 100 ul volume. This mix were incubated 15 min at RT and added to the wells 
having 2 ml serum positive media.  
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Figure 16  hnRNP F was purified by ion-exchange and metal affinity columns from E. coli 
extracts.  BI, AI, SPT and FLT stand for Before Induction, After Induction, Supernatant and Flowthrough, 
respectively. 
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Figure 17  hnRNP H was purified by glutathione-speharose and ion-exchange columns from E. 
coli extracts.  
 
RNAi transfection: 
 
Approximately 1.5x105 cells were seeded on each well of 6-well plates a day before the 
transfection. A total of 200 ul transfection mix including 0.1 nmol duplex siRNA, 8 ul Amine 
transfection reagent (Ambion) and serum free DMEM was added to each well having 800 ul 
media with serum, essentially according to  the manufacturer’s instructions. After 20-24 hour 
incubation the media was exchanged with 2 ml fresh serum positive media with serum. After a 
total of two days of incubation, cells were transfected with pEGFP based plasmids as explained 
above.  They were then harvested after 24 hours of incubation for flow cytometry. The identical 
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 region in hnRNP F and hnRNP H is targeted with the RNAi experiments. The siRNA sequences 
are given below. The region targeted at the hnRNP H1 message is identical in hnRNP H2 i.e. the 
same siRNA duplex is effective both for hnRNP H1 and H2. Furthermore three mismatches 
between hnRNP F and H transcripts in this region ensured that there is no cross reactivity. The 
differences between hnRNP F and H siRNAs are highlighted. 
 
siRNA for hnRNP F (Ambion siRNA lot # 044786siB) :   
GGUGUCCAUUUCAUCUACAtt 
UGUAGAUGAAAUGGACACCtg 
 
siRNA for hnRNP H1 (Ambion siRNA lot # 048945si) : 
GGUAUUCGUUUCAUCUACAtt 
UGUAGAUGAAACGAAUACCtt 
 
 
Overexpression: 
Plasmids having the hnRNP F and hnRNP H2 ORF have pCMV-flag (Sigma) backbone and 
were described in  (Veraldi et al. 2001).  hnRNP F, H2 or empty vector plasmid were transfected 
to 293T cells with the Fugene 6 reagent and allowed to overexpress for 24 hours then the very 
same cells were retransfected with the pEGFP based plasmids for two days and they are 
harvested for flow cytometry or western blots. 
 
Flow Cytometry  and Western Blot 
After incubating 18-41 hours in media, cells were washed with 1xPBS and trypsinized 
with 0.5 ml 1xTrypsin for 1 min. Cells were spun down in 5 ml Falcon tubes. Cell pellets were 
sequentially washed with 1xPBS and then with 1xFACS buffer (5% FCS, 1xPBS, 0.01% 
NaAzide). Finally, cells were fixed in 1xParaformaldahyde in 1xPBS.  
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 All the flow cytometry experiments were performed with a single 488 nm laser. Both 
GFP and DsredExpress proteins were excited with 488nm laser and emissions were recorded in 
FL1 (green) and FL2 (red) or FL3 (red) channel  A total of 5-20x103 events were recorded for 
each sample. The analysis was done with the WinMdi software available at 
http://facs.scripps.edu/software.html (November 2004). 
All the flow cytometry experiments were performed with the Coulter Epics XL flow cytometer 
operating with a single 488 nm laser. Both GFP and DsredExpress proteins were excited with 
488nm laser and emissions were recorded in FL1 (green) and FL3 (red) channel. A modest 
compensation was done by subtracting 3.7% of the FL1 channel from FL3.  A total of 5-20x103 
events were recorded for each sample.  
Western blots were performed as described in (Martincic et al. 1998). Anti-GFP and anti-
DsredExpress antibodies were purchased from Clontech whereas anti-Neomycin antibody was 
obtained from Upstate Biochemical Cell Signaling Solutions. 
Fluorescent Microscopy 
Fluorescent images of monolayer live cells were captured from six well plates with a Nikon TS-
100 microscope.  GFP is excited with 425 nm and emission was recorded at 500 nm whereas 
DsredExpress was excited with 545 nm and the emission is recorded at 620 nm. The gain and 
exposure settings are identical for all images. Each original image has 1600x1200 pixels and 24 
bit color. 
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 5. MANUSCRIPT TWO: GLOBAL GENE EXPRESSION ANALYSIS REVEALS  
NOVEL B-CELL STAGE SPECIFIC GENES THAT ARE REGULATED BY HNRNP F.  
5.1. ABSTRACT 
In an attempt to identify the factors that play a role in the membrane to secretory specific 
Immunoglobulin (Ig) switch in Plasma cells, we performed gene expression analysis on a macro 
scale with Affymetrix oligonucleotide based murine chip U74Av2 and two pairs of samples. The 
first group consists of AxJ plasmacytoma and A20 B-cell lymphoma cell line. An extensive list 
of B-cell stage specific genes were obtained. While many genes are expected to be important or 
required for B-cell development, we are particularly interested in the candidate transcripts that 
may have a role in membrane to secretory Immunoglobulin (Ig) switch. In order to get the 
candidate transcripts that both have a role in Ig secretion and are regulated by hnRNP F protein, 
we also performed array experiments with hnRNP F overexpressing AxJ cells and compared its 
gene expression profile to empty vector transfected AxJ. Each experiment has been performed at 
least twice with a biological replicate. Extensive gene ontology analysis revealed three major 
functional protein classes that are important in secretory Ig switch: defense response, signal 
transduction and nucleic acid metabolism. Finally, ELL-related RNA polymerase II, elongation 
factor (ELL 2) is induced in Plasmacytoma cells whereas it is repressed upon forced expression 
of hnNRP F. A model regarding Ig secretion, involving ELL 2 is proposed.  
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 5.2. INTRODUCTION 
The immunoglobulin heavy chain genes represent one of the best studied examples of 
developmentally regulated polyadenylation. Ig γ heavy chain is diagrammed in Figure 18. The 
maturation of B cells to Ig-secreting plasma cells is associated with an increase in the ratio of 
secreted (sec) to membrane (mb) form Ig mRNAs which differ in their 3’ termini. Since selection 
of the promoter proximal Ig γ-sec polyA site excludes the splicing downstream to the Ig γ-mb 
exons, early studies stressed the importance of the recognition of the suboptimal 5’ splice site for 
maintaining Ig γ sec:mb ratio. However, there is now a strong support for the idea that an 
increase in Ig γ-sec polyA site selection is due to increase in polyadenylation efficiency. 
The Ig γ-sec polyA site has been shown to be weaker than the Ig γ -mb polyA site. The 
observation that an increase in the cleavage/polyadenylation efficiency, but not splicing, 
correlated with the maturation of B-cells to plasma cells suggests that polyadenylation/cleavage 
at the proximal site is the regulated process (Peterson et al. 1991). While overexpression of CstF-
64 in chicken B lymphoma cells shifts the polyA site selection balance to secretory site 
(Takagaki and Manley 1998), an increase in the binding of activity of CstF-64 but not the 
amount was observed in mouse plasmocytoma cell line AxJ compared to lymphoma cell line 
A20 (Edwalds-Gilbert and Milcarek 1995). Previously, an increase in the level CstF-64 was 
observed during the transition from G0 to S phase (Martincic et al. 1998). However the fact that 
this change is not accompanied by increased binding activity of CstF-64 and increased 
polyadenylation efficiency in primary B-cells strongly suggests that the binding activity but not  
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 the absolute level of CstF-64 is one of the determining factors on polyA selection on Ig µ locus. 
The Ig µ-sec polyA site was replaced by other weak polyA sites without disturbing the sec:mb 
ratio in mouse B-cell lymphoma A20 and mouse plasmocytoma AxJ cells (Matis et al. 1996). 
This suggests that the  regulation is accomplished without regulatory cis-elements (Matis et al. 
1996). An increase in CstF-64 binding activity was also observed in Adenovirus (Mann et al. 
1993) and Herpesvirus (McGregor et al. 1996) infections without a change in the level protein. 
These findings strongly argue for the existence of accessory, tissue-specific factors that influence 
the binding activity of CstF-64  and/or activities of other basal factors, which influence hence 
polyadenylation efficiency. 
In an effort to characterize B-cell stage specific polyadenylation factors, an in vitro 
purification method of polyadenylation complexes was developed (Veraldi et al. 2001). Veraldi 
et al adapted a HeLa splicesome purification scheme (Reed 1990) to purify polyadenylation 
complexes formed on various polyadenylation sites. While polyadenylation complexes were 
successfully isolated with this method, a larger complex devoid of polyadenylation factors was  
reproducible observed. hnRNP F and hnRNP H/H’ proteins were found in this complex when it 
is formed by A20 B-cell lymphoma but not AxJ Plasmacytoma cells.  
Overexpression of hnRNP F in AxJ cells resulted in the less frequent usage of the 
secretory specific polyA site on Immunoglobulin pre-mRNA. In other words, hnRNP F was able 
“revert” the B-cell clock. We did global expression analysis of the hnRNP F overexpressing cells 
and compared the expression profile with empty vector transfected AxJ cells. Moreover, we are 
particularly interested in the hnRNP F target genes that are also differentially expressed in a B-
cell stage specific manner. To obtain these candidate transcripts, we also have performed 
microarray experiments with AxJ Plasmacytoma and A20 B-cell lymphoma cells. 
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Figure 18 Alternative processing of Ig γ chain pre-mRNA result either in secretory or membrane specific IG.  
If promoter proximal and distal polyA site is used, secretory and membrane specific mature transcript will be synthesized, respectively. 
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5.3. RESULTS 
There are many B-cell stage specific genes that were identified before (Underhill et al. 2003). By 
using microarray technology, we wished  to get an extensive list of transcripts whose expression 
varies in our model system, the A20 lymphoma/ memory cell line and the AxJ plasma cell we 
derived from it. The affymetrix murine U74Av2 chip has probes that represent more than 12000 
transcripts. We have performed separate array experiments with A20 and AxJ samples and 
compared the gene expression profile. The signal values of each chip was normalized before 
comparison. We found 207 transcripts that are differentially expressed in AxJ plasmacytoma 
cells; there are about equal number of induced and repressed transcripts. There are about an 
equal number of induced and repressed genes. Gene ontology analysis was performed with this 
group of genes (www.affymetix.com, December 2004). By making this analysis, we were able to 
get the potential functional class, molecular activity and cellular localization of each transcript. 
Of our particular interest are the transcripts that are important for DNA and RNA metabolism. 
The transcripts that are induced in AxJ cells that have a role in DNA and RNA metabolism are 
given in Table 7. A similar table was also established with the transcripts repressed in AxJ 
(Table 8). There are more transcripts in the latter table. Moreover, transcription factors make up 
the vast majority in both cases.  Among the polyadenylation factors CPSF-2 (CPSF-100) is 
repressed in AxJ cells. 
The same Affymetrix U74Av2 arrays were used with hnRNP F transfected AxJ samples. The 
hnRNP F was stably transfected into AxJ plasmacytoma cells; the gene expression profile of the 
transfected cells was compared with the empty vector transfected AxJs. There are 31 
differentially expressed genes upon forced expression of hnRNP F (Table 9); all of them are 
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 repressed. This is in parallel to hnRNPF’s experimentally shown negative effect on 
polyadenylation (Veraldi et al. 2001) When the sets of differentially expressed transcripts in 
Plasmacytoma cells and hnRNP F overexpressing AxJ cells were intersected, three genes were 
obtained (Figure 19). Since hnRNP F somehow reverts the B-cell clock with respect to Ig 
secretion, we are particularly interested in genes with the opposite expression patterns i.e. 
transcripts that are induced in one case and repressed in the other. Elongation factor RNA 
Polymerase II 2 (ELL 2) is induced in Plasmacytoma cells whereas it is repressed about 3 fold by 
hnRNP F overexpression according to microarray results (Table 10). Purified ELL2 protein was 
shown to enhance the elongation rate of RNAP II (Shilatifard et al. 1997). An RT-PCR was 
performed to verify the array data corresponding to ELL2: This gene is highly induced in AxJ 
and repressed slightly in hnRNP F overexpressing AxJs (Figure 20). Ribosomal protein S16 was 
used the control for the assay. Not only does expression of S16 not change in any of the samples 
used in this study but it is also expressed at very high levels. 
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 Table 7   Transcripts that are induced in AxJ Plasmacytoma cells. 
Probe Set ID Gene Title PC vs B 
102764_at tumor rejection antigen P1A 400.011
93573_at metallothionein 1 309.973
93728_at transforming growth factor beta 1 induced transcript 4 287.109
96597_at plasmacytoma expressed transcript 2 231.070
99420_at immunoglobulin heavy chain 4 (serum IgG1) 215.381
101883_s_at X-linked lymphocyte-regulated 3b 185.845
93833_s_at histone 1, H2bc 162.241
100583_at immunoglobulin heavy chain, (J558 family) 143.662
99436_at sialophorin 78.357
99065_at casein kappa 60.573
101561_at metallothionein 2 55.896
93287_at Bcl2-interacting killer-like 54.912
94288_at histone 1, H1c 52.532
104063_at Src activating and signaling molecule 47.622
96146_at B-cell translocation gene 3 47.372
101082_at malic enzyme, supernatant 47.018
99667_at cytochrome c oxidase, subunit VI a, polypeptide 2 40.164
102313_at GTP cyclohydrolase 1 38.509
160623_at cyclin-dependent kinase-like 2 (CDC2-related kinase) 37.984
92904_at PR domain containing 1, with ZNF domain 33.809
93039_at plasma glutamate carboxypeptidase 32.185
98435_at adenylosuccinate synthetase 1, muscle 29.504
101056_at radixin 28.329
93638_s_at immunoglobulin lambda chain, variable 1 26.281
96831_at protein disulfide isomerase-related 23.752
104299_at NEW1 domain containing protein 23.087
96134_at deleted in polyposis 1-like 1 21.248
97819_at glutathione S-transferase omega 1 19.109
99935_at tight junction protein 1 17.659
103029_at programmed cell death 4 13.772
92871_at Sel1 (suppressor of lin-12) 1 homolog (C. elegans) 13.258
98007_at ribosomal protein S6 kinase, 90kD, polypeptide 2 12.843
102060_at golgi autoantigen, golgin subfamily a, 4 12.640
95419_at H1 histone family, member 0 12.576
95673_s_at brain abundant, membrane attached signal protein 1 12.376
104618_at retinoblastoma binding protein 9 12.232
100286_at macrophage stimulating 1 (hepatocyte growth factor-like) 12.079
101359_at laminin, beta 2 11.896
102221_at synaptogyrin 1 11.835
94247_at E26 avian leukemia oncogene 2, 3' domain 11.253
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 161666_f_at growth arrest and DNA-damage-inducible 45 beta 10.888
104627_at CDP-diacylglycerol synthase  2 10.717
102237_at CD28 antigen 10.422
104256_at pleckstrin homology, Sec7 and coiled/coil domains, binding protein 10.404
93593_f_at epithelial membrane protein 3 9.740
101040_at calpain 2 9.482
161486_f_at immunoglobulin heavy chain, (J558 family) 9.131
161754_f_at galactosidase, beta 1 8.994
101900_at cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) 8.869
95675_at germinal center kinase-like kinase-like 8.631
160499_at tumor rejection antigen gp96 8.106
92870_at Sel1 (suppressor of lin-12) 1 homolog (C. elegans) 7.536
104257_g_at pleckstrin homology, Sec7 and coiled/coil domains, binding protein 7.325
160520_at yes-associated protein 7.315
104712_at myelocytomatosis oncogene 7.235
93320_at carnitine palmitoyltransferase 1, liver 6.992
92891_f_at homeo box C9 6.738
101123_at integral membrane protein 2B 6.678
99582_at tumor-associated calcium signal transducer 1 6.671
104476_at retinoblastoma-like 1 (p107) 6.648
103723_at interleukin 13 receptor, alpha 1 6.406
102955_at nuclear factor, interleukin 3, regulated 5.718
160119_at matrix gamma-carboxyglutamate (gla) protein 5.696
103895_at expressed sequence AW549877 5.570
97876_at vacuolar protein sorting 29 (S. pombe) 5.360
92611_at GPI-anchored membrane protein 1 5.288
103892_r_at ELL-related RNA polymerase II, elongation factor 5.246
99532_at transducer of ErbB-2.1 5.236
100606_at prion protein 5.047
96650_at AU RNA binding protein/enoyl-coenzyme A hydratase 4.993
95423_at calcium binding protein, intestinal 4.992
93083_at annexin A5 4.869
99475_at suppressor of cytokine signaling 2 4.798
103647_at galactosidase, beta 1 4.748
93495_at peroxiredoxin 4 4.630
100136_at lysosomal membrane glycoprotein 2 4.527
102655_at integrin alpha 4 4.427
102316_at calpain 5 4.373
104538_at prostaglandin I2 (prostacyclin) synthase 4.353
100622_at anti-oxidant protein 2 4.341
96633_s_at MORF-related gene X 4.225
93870_at Braf transforming gene 4.210
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 104006_at epidermal growth factor receptor pathway substrate 15 4.165
92737_at interferon regulatory factor 4 4.091
96752_at intercellular adhesion molecule 3.566
104065_at ER degradation enhancing alpha mannosidase-like 3.537
98059_s_at lamin A 3.353
100572_at transmembrane 9 superfamily member 2 3.329
 
 
 
 
Table 8   Transcripts that are repressed in AxJ Plasmacytoma cells. 
Probe Set ID Gene Title PC vs  B cells
92564_at leucine rich repeat (in FLII) interacting protein 1 0.349
93797_g_at ATPase, Na+/K+ transporting, alpha 1 polypeptide 0.242
101869_s_at hemoglobin, beta adult major chain 0.237
94970_at hypothetical protein LOC232314 0.232
96753_at B-cell CLL/lymphoma 7C 0.224
102337_s_at Fc receptor, IgG, low affinity IIb 0.224
160611_at expressed sequence AW111961 0.214
97335_at T-cell immunoglobulin and mucin domain containing 2 0.213
99461_at hematopoietic cell specific Lyn substrate 1 0.213
99478_at protein tyrosine phosphatase, receptor type, C polypeptide-associated protein 0.210
92678_at DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 25 0.205
102796_at nucleoplasmin 3 0.195
100564_at D-dopachrome tautomerase 0.193
93626_at ATP-binding cassette, sub-family G (WHITE), member 2 0.193
94161_at protein kinase C, epsilon 0.184
99945_at CD19 antigen 0.181
100065_r_at gap junction membrane channel protein alpha 1 0.169
104603_at glutathione S-transferase, theta 2 0.165
102208_at sialyltransferase 10 (alpha-2,3-sialyltransferase VI) 0.165
101147_at germinal center expressed transcript 0.164
160545_at cyclin D3 0.159
101845_s_at component of Sp100-rs 0.152
93633_at guanine nucleotide exchange factor (RCC1 related) 0.150
92644_s_at myeloblastosis oncogene 0.149
99071_at macrophage expressed gene 1 0.147
98962_at lipase, hepatic 0.143
103959_at hypothetical protein LOC230936 0.142
103462_at dedicator of cyto-kinesis 2 0.140
160246_at expressed sequence AA987150 0.140
160064_at syntaxin 7 0.133
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 93104_at B-cell translocation gene 1, anti-proliferative 0.132
92895_at single-minded 1 0.127
94332_at hypothetical protein LOC270138 0.127
100467_at lymphoblastomic leukemia 0.127
102644_at kidney cell line derived transcript 1 0.126
101019_at cathepsin C 0.119
92359_at B lymphoid kinase 0.118
93285_at dual specificity phosphatase 6 0.116
95129_at nuclear receptor co-repressor 2 0.115
102037_at microtubule-associated protein, RP/EB family, member 2 0.114
98002_at interferon concensus sequence binding protein 0.114
99486_at centromere autoantigen B 0.112
98992_at endothelial precursor protein B9 0.105
94285_at histocompatibility 2, class II antigen E beta 0.104
102778_at CD79A antigen (immunoglobulin-associated alpha) 0.103
160101_at heme oxygenase (decycling) 1 0.103
103571_at leukocyte specific transcript 1 0.099
101834_at mitogen activated protein kinase 3 0.098
101918_at transforming growth factor, beta 1 0.098
102292_at growth arrest and DNA-damage-inducible 45 alpha 0.096
98588_at fumarylacetoacetate hydrolase 0.093
161899_f_at Williams-Beuren syndrome chromosome region 5 homolog (human) 0.091
100998_at histocompatibility 2, class II antigen A, beta 1 0.086
95511_at integrin alpha 6 0.083
103795_f_at T-cell immunoglobulin and mucin domain containing 2 0.083
96648_at coronin, actin binding protein 1A 0.081
103288_at nuclear receptor interacting protein 1 0.080
93372_at acidic (leucine-rich) nuclear phosphoprotein 32 family, member A 0.074
98398_s_at apolipoprotein B editing complex 1 0.073
104652_at potassium channel, subfamily K, member 2 0.068
101851_at antigen identified by monoclonal antibody MRC OX-2 0.067
93567_at profilin 2 0.067
101426_at ceramide kinase 0.065
92962_at tumor necrosis factor receptor superfamily, member 5 0.064
95893_at B lymphoid kinase 0.060
98508_s_at phosphatidic acid phosphatase 2a 0.060
102851_s_at hemopoietic cell phosphatase 0.056
97963_at signal-induced proliferation associated gene 1 0.055
92407_at myomesin 1 0.053
92535_at early B-cell factor 1 0.053
104173_at membrane-spanning 4-domains, subfamily A, member 1 0.052
104174_at ectonucleotide pyrophosphatase/phosphodiesterase 1 0.049
98790_s_at myeloid ecotropic viral integration site 1 0.048
103690_at Williams-Beuren syndrome chromosome region 5 0.045
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 homolog (human) 
99841_at Burkitt lymphoma receptor 1 0.044
94834_at cathepsin H 0.038
94056_at stearoyl-Coenzyme A desaturase 1 0.038
92867_at polyhomeotic-like 2 (Drosophila) 0.036
102798_at adrenomedullin 0.035
101441_i_at inositol 1,4,5-triphosphate receptor 5 0.034
94432_at sialyltransferase 1 (beta-galactoside alpha-2,6-sialyltransferase) 0.033
101972_at kidney-derived aspartic protease-like protein 0.033
92415_at tumor necrosis factor (ligand) superfamily, member 9 0.031
102904_at histocompatibility 2, class II antigen E alpha 0.031
92496_at vesicle-associated membrane protein 5 0.029
92760_at Wiskott-Aldrich syndrome homolog (human) 0.029
102629_at tumor necrosis factor 0.028
99511_at protein kinase C, beta 0.028
94354_at ATP-binding cassette, sub-family A (ABC1), member 1 0.027
102209_at nuclear factor of activated T-cells, cytoplasmic 1 0.026
96591_at reelin 0.024
102939_s_at CD22 antigen 0.023
98129_at thymosin, beta 10 0.022
99446_at membrane-spanning 4-domains, subfamily A, member 1 0.021
162287_r_at chloride channel calcium activated 3 0.019
102940_at lymphotoxin B 0.018
96736_at expressed sequence AA959454 0.018
92494_at annexin A10 0.017
102630_s_at lymphotoxin A 0.017
99510_at protein kinase C, beta 0.017
100064_f_at gap junction membrane channel protein alpha 1 0.016
101878_at CD72 antigen 0.016
98525_f_at erythroid differentiation regulator 0.016
93657_at Mus musculus Ets transcription factor Spi-B, partial cds. 0.015
93013_at inhibitor of DNA binding 2 0.012
92642_at carbonic anhydrase 2 0.012
94057_g_at stearoyl-Coenzyme A desaturase 1 0.010
92866_at histocompatibility 2, class II antigen A, alpha 0.009
93842_at hypothetical protein MGC6998 0.008
93086_at immunoglobulin kappa chain variable 8 (V8) 0.008
103015_at B-cell leukemia/lymphoma 6 0.004
101368_at placentae and embryos oncofetal gene 0.002
96426_at thymosin, beta 4, X chromosome 0.002
103794_i_at T-cell immunoglobulin and mucin domain containing 2 0.001
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 Table 9   Differentially expressed transcripts upon forced expression of hnRNP F in AxJ 
Plasmocytoma cells. 
 
Probe set ID Gene Title F vs AxJ 
96651_at SWI/SNF related , actin dependent regulator of chromatin, subfamily e, member 1 0.271 
102655_at integrin alpha 4 0.288 
103892_r_at ELL-related RNA polymerase II, elongation factor 0.343 
92579_at Sjogren syndrome antigen B 0.364 
102981_at GA repeat binding protein, alpha 0.370 
161076_at hypothetical protein MGC36997 0.389 
103654_at nucleosome binding protein 1 0.398 
160626_at myelin basic protein expression factor 2, repressor 0.402 
93646_at PTK9 protein tyrosine kinase 9 0.412 
98048_at neural-salient serine/arginine-rich 0.413 
93228_at helicase, lymphoid specific 0.416 
93878_at myeloid/lymphoid or mixed lineage-leukemia translocation to 10 homolog (Drosophila) 0.423 
103045_at mature T-cell proliferation 1 0.425 
100903_at ADP-ribosyltransferase (NAD+; poly(ADP-ribose) polymerase)-like 2 0.431 
93806_at SH3-binding domain glutamic acid-rich protein like 0.446 
99343_at retinoblastoma binding protein 7 0.446 
160539_at splicing factor, arginine/serine-rich 1 (ASF/SF2) 0.446 
104476_at retinoblastoma-like 1 (p107) 0.448 
95606_at NS1-associated protein 1-like 0.448 
104070_at p300/CBP-associated factor 0.449 
93309_at fibroblast growth factor inducible 14 0.450 
161980_f_at Bcl2-associated athanogene 3 0.452 
161648_at complement receptor related protein 0.452 
97182_at cyclin E2 0.472 
161126_at ESTs, Moderately similar to  enhancer of invasion 10 [Homo sapiens] [H.sapiens] 0.473 
93773_f_at zinc finger protein 265 0.479 
97102_at YME1-like 1 (S. cerevisiae) 0.479 
97541_f_at histocompatibility 2, D region locus 1 0.480 
101370_at karyopherin (importin) alpha 1 0.483 
100560_at platelet-activating factor acetylhydrolase, isoform 1b, beta1 subunit 0.483 
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Figure 19 Venn diagram showing that three transcripts are differentially expressed both in Plasma 
cells and hnRNP F overexpressing AxJ cells.   
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Table 10 B-cell specific genes that are regulated by forced hnRNP F expression.  
Probe Set ID Plasma-Bcell ratio 
F-AxJ 
ratio Gene Title 
102655_at 4.43 0.29 integrin alpha 4 
103892_r_at 5.25 0.33 elongation factor RNA polymerase II 2 
104476_at 6.65 0.45 retinoblastoma-like 1 (p107) 
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Figure 20 ELL2 is in
 
 
 
 
 RT-PCduced in AxJ cells compared to A20 cells as assayed by RT-PCR 
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 5.4. CONCLUSIONS 
Development from B-cell to a plasma cell includes radical morphological and functional 
changes. Therefore, it is not surprising that the expression of more than 400 genes were modified 
in AxJ Plasmacytoma cells versus its lymphoma predecessor. The candidate genes that have a 
role in membrane to secretory Immunoglobulin switch are broadly classified into an RNA 
metabolism class which include splicing and polyadenylation factors. Among the transcripts 
repressed in AxJ cells is the Cleavage and Polyadenylation Specific Factor 2 (CPSF-2 aka CPSF-
100). However, the CPSF2 protein levels do not seem to change between different B-cell stages 
(Edwalds-Gilbert and Milcarek 1995) a fact that might indicate a negative posttranscriptional 
control for this transcript. 
The ELL protein family contains ELL, ELL2 and ELL3. They all the enhance elongation rate of 
RNAP II (Shilatifard 1998). With promoter that varied in their RNAP II elongation rates and 
processivity properties weak alternative splice sites are more often skipped and the reverse 
statement is also true: the slower and less processive the RNAP II, the higher the chance that it 
will recognize suboptimal splice sites (Nogues et al. 2003) (Nogues et al. 2003). However, 
recognition of the optimal splice sites, i.e constitutive splice sites, is not effected by the RNAP II 
elongation rate (Nogues et al. 2003). A model for membrane to secretory Immunoglobulin 
switch that includes ELL2 is proposed (Figure 21). We propose that when ELL2 is induced in Ig-
secreting cells, RNAP II becomes more processive. This will result in the skipping of a weak 
membrane specific 5’ splice site. In early B-cells, the level of ELL2 is low and RNAP II would 
be expected to be less processive. In this way, the splicing machinery will have more time to 
recognize the suboptimal membrane specific splice site imbedded in CH3 and use it more 
frequently. 
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 Interestingly, the ELL2 primary transcript has two polyadenylation signals that are 2 kb apart; it 
is possible that the mechanism of repression of ELL2 by hnRNP F includes alternative 
polyadenylation. Splicing factor SF2/ASF was also repressed by hnRNP F in the array data. 
Preliminary RT-PCR results showed similar levels of SF2/ASF in both hnRNP F and empty-
vector transfected AxJs. However, SF2/ASF has two functional polyA signals, too, and the 
regulation of SF2/ASF expression by hnRNP F may also include alternative polyadenylation 
which does not change the overall levels of the transcript. These two sites are about 100 nt apart. 
Both ELL2 and SF2/ASF full-length transcripts have consecutive Guanines in their 3’ UTR. 
Preliminary binding studies with recombinant hnRNP F and portions of 3’ UTR of ELL2 and 
SF2/ASF confirmed that hnRNP F indeed binds to their 3’ UTR (data not shown) 
Evaluation of array data should be interpreted with caution for several reasons. First, there are 
many transcripts that have multiple representative probes on the chip. The expression values do 
not always correlate perfectly. Although this may indicate alternative processing of the 
messages, it may also result from imperfect design and/or hybridization of the probes. In 
addition, there are many probes which partially represent the corresponding transcript. For 
example, if the total length of the probe (oligonucleotides) is 250 nucleotides, not all of these 
sequence are specific to its designed transcript. However the expression data is obtained from the 
full probe. 
The probability of getting three transcripts that are differentially expressed both in Plasma cells 
and hnRNP F overexpressing plasma cells is about 1.52x10-5.  Assuming that the selection of 
207 transcripts in Plasma vs B-cell set and 31 genes in hnRNP F vs Empty vector set are random, 
the probability of getting three common genes is about 1.52x10-5 ; confirming that getting three 
transcripts is not an artificial result. 
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 All the unidentified cDNAs, EST probes for DNA segments were removed for our analysis. 
First, there were already a very high number of transcripts to deal with. Second, most of these 
cDNAs do not match to any protein, motif or domain already known to have a role in RNA 
metabolism. 
Extensive analysis of the array experiments performed in this study resulted in a novel gene 
(ELL2) and a unique mechanism for the membrane to secretory Ig expression. 
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 5.5. METHODS 
 
Two sets of array experiments were performed in this study. For the first part, biotin labeled 
cRNAs were synthesized from polyA plus RNA samples in our lab according to Affymetrix 
instruction. These samples were sent to Center for Applied Genomics at University of Medicine 
and Dentistry of New Jersey to be hybridized with Affymetrix U74Av2 murine oligonucleotide 
chips. Each cRNA sample was hybridized to chips separately and each data comparison is a 
result of two separate hybridization. After normalization of signals among different chips, each 
probe is scored either “Present” or “Absent” by the Affymetrix software depending on the 
overall signal strength. There are three different analysis steps that were taken: First we 
performed Significance Analysis of Microarray (SAM) which is basically a unpaired t-test on a 
large scale (Tusher et al. 2001). Second, the induction and repression cutoff point was taken as 
two. Last but not least, we exclude the transcripts thatare induced in one sample and absent at the 
same time. 
Total RNA were isolated from cells corresponding to second set and submitted for cRNA 
synthesis and hybridization to the University of Pittsburgh Genomics and Proteomics Laboratory 
Array facility. The same U74Av2 chips were used to ensure one to one comparison with the first 
data set. The same analysis explained above were done also with this set. All the raw data 
analysis was performed with Microsoft Excel software. Gene ontology analysis was performed at 
www.affymetrix.com. 
RT-PCR 
Reverse transcription was performed according to manufacturer’s (InvitroGen) protocol. PCR 
program used for each amplification was: 30 cycles of 950 for 30 sec, 580 for 30 sec, 720 for 45 
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 sec . PCR products were fractionated on a 1% Agarose with a 75 min run at 100V in 0.5x TBE 
Buffer. 
6. DISCUSSION  
Gene expression control could be achieved at multiple different stages. While most of the control 
is exerted at the level of transcription, splicing, polyadenylation, mRNA stability and RNA 
editing offers the cell various gene control mechanisms. Most hnRNP proteins associate with 
RNA polII transcripts rapidly and increase the overall message stability in general. The hnRNP 
proteins bind to RNA via RRM or RGG domains. In most of the cases, RRM domains have been 
shown to have sequence specificity. The hnRNP H protein family displays a preference for 
Guanine rich sequences. The in vitro SELEX experiments with hnRNP H family have not been 
performed. In order to get the consensus hnRNP H binding sequence, a multiple alignment was 
performed with all the experimentally proven hnRNP H binding sequences. The minimal binding 
sequence element was used in each case. While several Guanines are present in every sequence, 
multiple alignment results showed a conserved Adenine (Figure 2) that is about 10 nt 
downstream of consecutive Guanines. The presence of this Adenine is not necessary since there 
are sequences that did not conserve this Adenine and still bind to hnRNP H (Figure 8). However, 
it may be required for optimal or high affinity binding. Interestingly, hnRNP F as well as hnRNP 
H2 bound the G-A mutants SAA10 and SAA11 with a higher affinity compared to wt GRS 
(Figure 9). Not only is the location of these mutations similar to consensus Adenine but also the 
full length SVL probe (Table 2) has this conserved Adenine residue. Other authors (Caputi and 
Zahler 2001) have implicated GGGA as the binding site for the hnRNP F/H? protein family. 
Although our data points out the importance of an Adenine residue, it is about 10 nt downstream 
of Guanine stretch, not immediately downstream. Furthermore, five, not three consecutive 
Guanines were required to reach the optimal affinity in our study. 
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 Regardless of binding sequence, hnRNP H binds to RNA with a higher affinity compared to 
hnRNP F. Since this phenomenon was  observed with the E. coli produced recombinant proteins, 
it may not result from posttranslational modifications. Because individual RRMs between 
hnRNP H and F are at least 90% identical, this difference also may not be due to primary RRM 
sequence. It is possible that the very C-terminal part of hnRNP H that is not present in hnRNP F 
is responsible for this observation. It will be useful to design chimera protein having N-terminal 
part of hnRNP F and C-terminal part of hnRNP H and assay sequence specific binding. Another 
useful construct maybe the one expressing a C-terminally truncated hnRNP H. 
Blocking the hnRNP H/F binding site on SVL polyA region has a negative effect on gene 
expression as assayed by Gfp-based reporter assays. This effect was verified by western blot, 
flow cytometry and fluorescent microscopy. The fact that it was observed with single polyA 
constructs implies that the relative effect of hnRNP F/H binding for alternative polyA site choice 
would be much greater. 
Development from B-cell to a plasma cell involves major changes of the levels of transcription 
factors including but not limited to Blimp-1, c-myc, Spi-B (Shapiro-Shelef and Calame 2004). 
This change brings major morphological and functional alterations. Whereas the memory B-cells 
have a 1:1 sec:mb Ig mRNA ratio,  typical plasma cells have an elevated sec:mb ratio. The 
choice between sec and mb specific message involves alternative splicing and alternative 
polyadenylation. In order to understand this B-cell stage specific switch, we compared the gene 
expression profile of A20 lymphoma with AxJ plasmacytoma cells. More than 400 transcripts 
are differentially expressed in AxJ cells. There are many genes related to DNA and RNA 
metabolism. hnRNP A1 and hnRNP C proteins are induced more than two fold in AxJ cells 
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 (Table 7). It would be worthwhile to try to show an interaction between these two proteins and Ig 
polyA region.  
There are no induced splicing factors in AxJ cells; Splicing factor 3a, SRp20, splicing factor 
proline/glutamine rich, and CUG triplet repeat RNA binding protein 2 are all repressed (Table 8). 
Whether the repression of these four splicing factor is decisive for mb:sec switch needs to be 
experimentally shown. 
The level of the CPSF-2 transcript is repressed in AxJ cells (Table 8) however its protein level 
has been shown not to change between A20 and AxJ cells (Edwalds-Gilbert and Milcarek 1995). 
The level of another polyA factor, CstF-64, does not change cite papers?(data not shown). 
There are many transcription factors repressed or induced in AxJ cells reflecting the major 
differences between these two cell lines. Interestingly, ELL2 mRNA is induced two-three fold in 
plasmacytoma cells (Table 7). There are two different probes that represent ELL2 in Table 7 and 
they are both induced. Purified ELL2 protein was shown to enhance the elongation rate of RNAP 
II. Recent studies implicate a relationship between the processivity of RNAP II and the usage of 
suboptimal splice sites.  Hence the change is ELL2 levels may be very significant for Ig 
expression. 
A complex of HnRNP F and H was shown to be formed on Ig polyA regions by early B-cell 
extracts but not plasma cell extracts. Overexpression of hnRNP F in plasmacytoma cells resulted 
in decreased useage of the secretory pA site compared to mock transfected cells. In order to 
understand the underlying mechanism of this effect, we performed microarray analysis of 
hnRNP F transfected plasmacytoma cells. There are about 30 differentially expressed transcripts; 
most of them are repressed genes. This is parallel to previously shown negative effect of hnRNP 
F on polyadenylation (Veraldi et al. 2001). SF2/ASF is one of the repressed transcripts upon 
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 hnRNP F overexpression. However preliminary RT-PCR results showed no significant changes 
between hnRNP F and mock transfected cells. Since hnRNP F was shown to revert the B-cell 
clock to some extent, we are particularly interested in genes that have opposite expression 
patterns between plasmacytoma vs lymphoma and hnRNP F overexpressing AxJ vs AxJ sets. 
There are three transcripts that fit into this definition (Table 10) you only show 3. messenger 
RNA for ELL2 is induced in Plasma cells whereas it is repressed in hnRNP F overexpressing 
AxJ cells. The RT-PCR results verified the induction of ELL2 RNA in AxJ cells compared to 
A20 cells (Figure 20), however the repression is marginal in hnRNP F transfected cells. A novel 
model for mb to sec Ig switch has been proposed (Figure 21). If ELL2 induction in plasma cells 
results in a more processive RNAP II, thesplicing machinery can skip the weak mb specific 
splice site. In memory and mature B-cells, ELL2 levels decrease and RNAP II becomes less 
processive and the mb specific splice site may be  used more frequently. 
The immediate obvious experiment can be the overexpression of ELL2 in early B-cells or 
downregulation of ELL2 in Plasma cells and then assaying the sec:mb transcript ratio. 
 
 
 
 
 
 
 
 
 
89 
  
 
7. GENERAL DISCUSSION AND CONCLUSION 
This study identified the consensus binding sequence of hnRNP F and H proteins. First, an 
extensive mutational analysis has been performed with the 14 nt GRS region on SVL RNA. The 
in vitro binding data channeled us to perform a multiple sequence alignment with all the 
experimental H/F binding sites. The consensus sequence includes a Guanine stretch, an Adenine 
that is 8-9 nucleotide downstream and an upstream Guanine.  
In order to show that hnRNP F and H binding to the 3’UTR has an effect on polyadenylation, 
polyadenylation assays were performed with the binding mutants. There is a subtle but 
reproducible decrease in polyadenylation efficiency. If the same mutation (SAA20) is cloned 
into the 3’UTR of gfp reporter gene on a plasmid, the GFP protein levels were diminished in 
parallel to the in vitro results. In addition, the SAA10 mutant SVL oligo bound to both hnRNP F 
and H better than the wt sequence. The similar cloning and transfection experiments yielded the 
expected increase in GFP levels. 
The hnRNP F and H levels were modulated by plasmid mediated overexpression and siRNA 
mediated RNAi and GFP levels were up and down, respectively. In summary, we have shown 
that hnRNP F and H has positive effect on gene expression with the SVL 3’ UTR. 
We performed two sets of microarray experiments; one set was designed to get the gene 
expression profile of A20 B-lymphoma and AxJ Plasmacytoma cell lines. In the other, we stably 
overexpressed hnRNP F  in AxJ cell line and compared the gene expression profile with the 
empty vector transfected cells. There are over 200 differentially expressed transcripts in Plasma 
cells. The hnRNP F effected the expression of 31 transcripts and there are only three 
differentially expressed genes in both sets. Interestingly, all the 31 hnRNP F target genes are 
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 down regulated. Overexpression of hnRNP F in 293T cells had a positive effect when GFP 
expression plasmid has SVL sequences in its 3’UTR. This can be explained in  multiple ways: 
First, the stable expression of hnRNP F resulted in the activation of feedback loop that 
overcompensated for the the effect of hnRNP F. explain more Second, stable transfection does 
not always result in direct effects i.e. the modulation of a protein levels may change the 
expression of another gene that in turn may be responsible for the observed phenotype. For 
example downregulation of ELL2 or ASF/SF2 may be responsible for the 31 downregulated ?? 
genes. Third, since both hnRNP F and H can bind to single stranded G-rich DNA, they are 
capable of binding also G-rich sequences in the promoter regions. Fourth, the hnRNP H and F 
are usually associated with splicing silencers so that the observed negative effect in the 
microarray study may be mediated by splicing.  
The primarily downregulation of genes of the  hnRNP F-array experiments might be explained in 
several ways. While the hnRNP F array data remains to be studied further, the unquestionable 
result from the first part of this study is that with the SVL constructs hnRNP F and H had a 
positive effect on protein expression through binding to the 3’ UTR. 
This study showed that polyadenylation is an important step for gene expression and hnRNP F 
and H modulates polyadenylation and hence can exert major influences on gene expression. 
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 8. FUTURE DIRECTIONS 
When (Veraldi et al. 2001) isolated polyadenylation complexes from nuclear extracts formed on 
polyA site containing RNA, a larger complex containing hnRNP H/F proteins was observed. 
However this “complex” was eluted in the void volume of the column. The void volume is the 
elution volume of molecules which are too large to enter even the largest pores of the filtration 
gel. This indicates that there are many unspecific proteins in this fraction and questions the 
nature and specificity of the H/F complexes. In order to improve the purification, size-exclusion 
chromotography should be repeated with a resin of higher resolution capacity such as S-1000 
Sephacryl (Amersham-Pharmacia) media with 400 nm spherical particles instead of S-500. The 
S-500 media has a fractionation range (Mr) of only 4 × 104 - 2 × 107 while the S-1000 media has 
a much larger (Mr of 5 × 105 - > 108 ) which would help to resolve the much larger protein 
complex that includes the hnRNP H/F. Apart from the resolution of the chromatography, the 
differential association hnRNP H/F on the polyA containing RNA should be verified with 
multiple different B-cell lines representing early or memory B-cell stage and Plasma cells. The 
confirmation of the results with sorted primary B-cell and Plasma extracts would complete the 
picture. The specificity of the H/F complexes would be ensured by mutating their binding 
regions on RNA and let the H/F complex be formed on the mutant RNA. 
Once the identity and nature of the H/F and polyadenylation complexes are verified in multiple 
cell lines, then the analytical analysis of the proteins by mass spectrometry present in these 
complexes would be helpful to try to isolate other auxiliary modifiers of polyadenylation. The 
functionally more important proteins that have the potential to modify polyadenylation should be 
in the polyadenylation complex not in the H/F complex.  However given the experimental 
ground in this study showing the effect of hnRNP F and H on polyadenylation, it is worthwhile 
to verify the specific nature of larger complex having hnRNP F/H.  
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Since this study successfully applied siRNA mediated RNAi for hnRNP F and H, one can 
downregulate these two proteins in A20 B-lymphoma cell line and assay Ig sec:mb message 
ratio. Furthermore, to complement the hnRNP F array data present in this study, one can 
downregulate hnRNP F in AxJ cells and assay the levels of 31 hnRNP F target genes by RT-PCR 
or Northern blot without the need of doing the array experiment. If the 31 genes are direct 
hnRNP F targets, the levels of their expression will go in the opposite direction by hnRNP F 
RNAi as compared to overexpression. 
Having isolated the optimal hnRNP F and H binding site, one can search for these sequences in 
the 3’UTRs of mammalian transcripts on global scale. Before this study, practically this was not 
possible, since not only the consensus sequence was not defined but also the proposed H/F 
binding site (just a G-stretch) yielded many common matches. A profile of potential hnRNP F 
and H target genes would be formed after this computational analysis. 
A model that helps to explain the sec:mb ratio in B and Plasma cells was suggested in this study 
(Figure 21). In this model, ELL2 increases the elongation rate of RNAP II and this in turn results 
in skipping of the membrane specific weak splice site in Plasma cells. The situation is 
completely opposite in early/memory B-cells. If the model is true, then modulation of the ELL2 
levels would result in the expected switch in sec:mb ratio. One can perform RNAi for ELL2 in 
Plasma cells or overexpress it in B-cells and if the sec:mb phenotype is reversed, our model 
would gain some validity. Independent of ELL2, the elongation rate of RNAP II can be 
decreased by a drug called DRB. In addition, there is alpha-amanitin resistant “slow” RNAP II 
construct (de la Mata et al. 2003), one can make use of it to diminish the elongation rate if RNAP 
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 II in Plasma cells. But before pursuing this path, convincing data from ELL2 protein expression 
and deletion experiments have to be obtained. 
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